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CHAPTER I 
REVIEW OF THE LITERATURE AND 
STATEMENT OF THE PROBLEM 
The Disease 
Shipping fever, or pneumonic pasteurellosis of cattle has been 
reported to be the most prevalent and serious disease of feedlot 
cattle in North America (Thomson, 1980). In a survey of 10 veterinary 
practices, each involving 35,000 to 225,000 cattle annually, Jensen 
(1968) found that 40% to 80% of diseases encountered involved the 
respiratory system. In 1966 it was estimated that over 100,000 cases 
of bovine respiratory disease occurred in the United States and resulted 
in losses of approximately $75,000,000 (Abinanti, 1968). A more recent 
estimate of financial loss due to the disease was one third of a billion 
dollars annually (Morter et al., 1982). Actual mortality rates from the 
disease are generally low, particularly if adequate treatment is admini-
stered when clinical signs first appear. Thus the greatest costs of the 
disease involve loss of weight and condition and expenses connected 
with preventive programs and treatment measures, rather than actual 
death losses. 
The term shipping fever was first used to describe a large variety 
of respiratory ailments among cavalry horses (Turner, 1916). The same 
term was also used to describe respiratory diseases of cattle in the 
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early 1900's (Hardenbergh and Boerner, 1918). There was a great deal 
of confusion at that time about the etiology of the disease as well as 
about the distinction between various syndromes associated with the name. 
Literature references to diseases known variously as transport fever, 
fibrinous pneumonia, stockyard pneumonia, and exposure disease, all 
appear to refer to the nebulous array of diseases that eventually became 
known as the bovine respiratory disease complex. It is now known that 
this complex of diseases consists of at least three different clinical 
entities: (1) Enzootic pneumonia of calves, (2) shipping fever, and 
(3) atypical interstitial pneumonia (Lillie, 1974). Only within recent 
years has the term pneumonic pasteurellosis come into common use to 
indicate the acute, fulminating lobar fibrinous pneumonia associated 
with Pasteurella haemolytica infection in calves (Jubb and Kennedy, 1970). 
R....=_ haemolytica and R....=_ multocida have been known to be associated 
with bovine respiratory disease for many years. However, their signifi-
cance as pathogens was not fully appreciated because of the complex 
etiology of the disease. As early at 1895, Moore (1895) reported that 
Pasteurella spp. were present as commensals on the respiratory mucous 
membranes of normal animals (cattle, sheep, swine, dogs, and cats). 
Jorgenson (1925) later studied 250 cattle and confirmed these findings. 
In addition, he isolated the organism at necropsy from 4 animals that 
died of causes other than pneumonia and without lung lesions. He could 
not distinguish the bacteria isolated from healthy cattle from those 
isolated from diseased animals. Scott and Farley (1932) performed 
necropsies on 26 cattle from different herds affected with shipping 
fever. An organism called Pasteurella boviseptica at that time (see 
section on "The Organism") was isolated from 81% of the cases. It was 
also the only organism isolated in pure culture in cases diagnosed 
-3 
as shipping fever. In contrast, none of 83 normal lungs from a packing 
house yielded R...=_ boviseptica upon culturing. They thus concluded that 
R...=_ boviseptica was the most important bacteriological factor in shipping 
fever. However when taking Jorgenson's work into account they also 
stated, "while R...=_ boviseptica may be the primary bacteriological factor 
of shipping fever, the causative factor in the production of the disease 
should be looked for elsewhere" (Scott and Farley, 1932, p. 177). 
A major barrier to elucidating the role of Pasteurella organisms 
as contributors to the disease process as well as the efficacy of 
protective measures has been the difficulty in artificially reproducing 
the disease. Jorgenson (1925) was able to infect two cows experimentally 
after they had been transported and chilled. One was infected by inhala-
tion of an aerosolized culture and the other by feeding of 250cc of a 
24 hr broth culture of "~ boviseptica". Carter (1956b) exposed 19 
calves, most intranasally, with agar or broth cultures or lung tissues 
infected with R...=_ haemolytica. The calves were not purposely stressed. 
Eight of the 19 animals showed mild to moderate clinical signs of 
pneumonia. ~ haemolytica was recovered at necropsy from the lungs of 
all of these animals. He postulated that preexisting inapparent chronic 
pneumonias, indicative of viral infection, were present in some of his 
experimental calves and contributed to the severity of the P. 
haemolytica infections. 
During the 1950's, attention began to be focused on the combined 
effects of~ haemolytica and other infectious agents, and environmental 
stresses. Palotay and Christensen (1959) reported fever, respiratory 
distress, and one death in calves as a result of concurrent intra-
tracheal inoculation of P. haemolytica and the sporadic bovine 
encephalomyelitis agent. The next year Collier et al. (1960) super-
imposed a K.!_ haemolytica infection by aerosolization of cattle infected 
3 days previously with infectious bovine rhinotracheitis (IBR) virus. 
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In that way, they were able to produce clinical pneumonia in 2 of 4 
animals and a severe febrile reaction in all four •. Jericho et al. (1976) 
induced disease in 11 of 20 calves with a combination of IBR virus, 
K.!_ haemolytica, and stress (including weaning the day of virus exposure 
and daily temperature fluctuations of 77° F to 8° F). More consistent 
disease production has been achieved recently by such methods as 
intrabronchial injection of 106 - 107 live K.!_ haemolytica organisms/ml 
(Wilkie and Markham, 1979), and transthoracic intrapulmonic injection 
of 5xl09 live organisms/lung (Panciera and Corstvet, 1984). 
Current theories on the initiation of pneumonic pasteurellosis 
agree that!.=._ haemolytica is the most important agent in the final 
stages of the disease. Stresses of one kind or another (transportation, 
weaning, overcrowding, social acclimation, fatigue, temperature and 
humidity extremes, food and water deprivation, castration, dehorning, 
worming, vaccination procedures, etc.) are usually given credit for 
predisposing to most outbreaks. One development during stress is an 
increased production of adrenal corticosteroids which have been shown 
in vitro to impair ingestion by phagocytes (Stossel, 1973), and to 
block the release of chemotactic factors from alveolar macrophages and 
the binding of such factors to PMN's (Dyer, 1982). A number of 
infectious agents other than pasteurellae also have been implicated as 
predisposing factors. These include bovine herpes virus type I (IBR) 
(Jericho and Langford, 1978; Filion et al., 1983)., parainfluenza-3 
virus (Baldwin et al., 1967), bovine respiratory syncytial virus (Rossi 
and Kiesel, 1974), bovine virus diarrhea virus (Roth et al., 1981), 
Mycoplasma spp. (Hamdy et al., 1958; Hamdy, 1968), and others. 
A convincing hypothesis on the role of viral agents was put forth 
by Collier (1968). He reasoned that: 
... the pasteurellae have difficulty in establishing 
infection on intact epithelial membranes but enjoy an 
increasingly favorable growth medium once host epithelial 
cellular debris and serous fluid have been elicited by 
virus (p. 826). · 
Thus he felt that viral infection should simply be considered as an 
example of "physiological stress." Other investigators have established 
more active roles for viruses in depression of host phagocytic defense 
mechanisms. Attachment of influenza virus to rodent polymorphonuclear 
leukocytes (PMN) has been shown to inhibit leukocyte glycolysis and 
depress subsequent ingestion and killing of bacteria (Sawyer, 1969). 
Parainfluenza I virus infection of murine alveolar macrophages was also 
shown to retard ingestion of yeast cells and prevent phagosome-lysosome 
fusion needed for efficient intracellular killing of these fungi (Jakab 
et al., 1980). A very different effect of virus on alveolar macrophages 
was suggested by Markham et al. (1982), who stated that, 
.•. the effect of virus on macrophages may not be due to 
a direct effect on the phagocytic or killing capability of 
the cell itself, but rather on its ability to recruit 
additional cells, like the PMN, to aid in clearance of the 
bacterial inoculum (p. 288). 
Such reports suggest possible mechanisms of virus-induced suppression 




Whatever the predisposing factors, the critical event in production 
of pneumonic pasteurellosis appears to be rapid growth of.!'...=._ haemolytica~ 
or more rarely.!'...=._ multocida, in the nasopharynx and eventually in the 
lungs, due to gravitational drainage or inhalation of droplets within 
inspired air (Thomson, 1981). In a comparison of nasal swabs taken from 
200 apparently healthy cattle and 59 cattle wh~ch had been diagnosed 
as having clinical shipping fever, Pasteurella spp. were found in only 
3% of the normal calves, but in 60% of those with shipping fever 
(Hoerlein et al., 1961). During and after shipment and congregation of 
cattle in feedlots, both the number of animals carrying.!'...=._ haemolytica 
and the numbers of organisms per animal increases, as determined by 
cultures of nasal swabs (Thomson, 1980). The organism is thought to be 
spread from animal to animal by droplet nuclei produced during coughing 
and labored respiration of sick animals, or by contamination of feed and 
water containers with nasal exudates (Lillie, 1974). As the number of 
organisms on the nasal mucosa increases, the number of organisms 
presented to the lung also increases, so that eventually resistance 
mechanisms are overwhelmed. Biberstein and Thompson (1965) concluded 
that the virulence of.!'...=._ haemolytica depended on its ability to grow 
rapidly in an animal from a small inoculum to a population that is toxic. 
Originally it was thought that the toxicity of.!'...=._ haemolytica was 
due to release of endotoxin from lysed organisms (Carter, 1968; Lillie, 
1974). Keiss et al •. (1964) extracted endotoxin from a bovine strain of 
R..:_ haemolytica and concluded that endotoxin comprises approximately 
12.25% of the dry weight of the organism. Those investigators concluded 
that when such large numbers of organisms are present, as in. the lungs 
of cattle with shipping fever, endotoxin effects, including death, may 
be expected. It was more strongly stated by Lillie (1974, p. 237) that 
"the clinical signs of 'shipping fever', excluding the obvious hypoxia 
and dyspnea resulting from loss of a large percen~age of functional 
lung parenchyma, may be explained by endotoxicity." As early as 1960, 
G. R, Smith (1960) reported that a heat-killed (55° c. for 30 min) broth 
of P. haemolytica could kill lambs at only a slightly higher multiple 
dose than that of a living culture. The signs produced were thought to 
be due to endotoxin. 
Within the last few years, several investigators have shown that 
~ haemolytica toxicity is primarily due, rather, to a product of live, 
metabolically active organisms. The toxicity has also been shown to be 
species specific, in that it is limited to ruminants (Kaehler et al., 
1980b) and cell specific, in that it shows greater toxicity for leuko-
cytes and macrophages than for spleen cells or erythrocytes (Shewen 
and Wilkie, 1982). Live, but not heat-killed, bacteria were found to 
be toxic to cultured bovine alveolar macrophages (Benson et al., 1978). 
Similarly, live but neither heat-killed nor X-irradiated organisms were 
shown to kill bovine blood monocytes (Kaehler et al., 1980~). Markham 
and Wilkie (1980) reported that formalin-killed R..:_ haemolytica caused 
bovine cultured alveolar macrophages to detach from cover slips, but 
they were unable to show similar killing of suspended macrophages by a 
51 Cr-release assay. Further investigations revealed that K..:_ haemolytica 
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cultures in the logarithmic growth phase were more toxic than stationary-
phase cultures for bovine neutrophils (Berggren et al., 1981; Markham 
et al., 1982). 
The exotoxin produced by live organisms is now known as P. 
haemolytica cytotoxin. It was first alluded to by Benson et al., .(1978), 
who reported a "toxic factor" present in bacteria-free filtrates from 
organisms grown in tissue culture medium Ml99 containing 10-20% fetal 
bovine serum. Logarithmic-phase cultures off..:_ haemolytica were later 
reported to produce a soluble "toxin" that was released into the medium 
when the organisms were grown in RPMI 1640 medium (Berggren et al., 
1981). The toxin was shown to kill bovine neutrophils, causing them to 
lose their phagocytic capability. Because it affected phagocytes, the 
authors stated that it should be considered a virulence factor. The 
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same group of investigators performed the first characterization studies 
on the toxin itself. They showed a correlation between cytotoxin 
production and culture age; production peaked during the logarithmic 
growth phase and then decreased during the stationary phase of growth 
(Baluyut et al., 1981). They reported that molecular weight of the 
cytotoxic substance was 300,000 or more, and that it was heat labile, 
oxygen stable, and susceptible to extremes of pH. They further found 
that it was inactivated by trypsin, and did not contain detectable 
endotoxin or hemolytic activity. Partial purification off..:_ haemolytica 
cytotoxin by Himmel et al. (1982) resulted in a 150,000 molecular weight 
protein which reacted by double irrnnunodiffusion to antiserum prepared 
against all 12 serotypes of_!>_:_ haemolytica, but not to antiserum prepared 
against 15 different serotypes of P. multocida. Those researchers felt 
that the protein was capsular. Another group studying enzyme activity 
in crude cytotoxin preparations demonstrated both a neuraminidase and 
a novel protease (Otulakowski et al., 1983). They suggested that the 
protease might have a function in unmasking receptors for cytotoxin on 
phagocytes, or in cleaving and thus activating the toxin itself. 
Further purification and characterization of cytotoxin is obviously 
needed. At this time, however, even without more refined definition 
it appears to be an important factor in development of pneumonic 
pasteurellosis, because it can impair production of chemotactic factors 
by pulmonary alveolar macrophages and kill bovine phagocytes 
(Markham et al., 1982). 
The Organism 
In 1885, Kitt and coworkers described an organism associated with 
the shipping fever complex (Kitt et al., 1885), and they named it 
Bacterium bipolare multocidum. The organism was indistinguishable 
culturally from that which had been described five years earlier by 
Pasteur (1880) as the cause of fowl cholera, as well as from the 
bacterium associated with swine plague and septicemia of rabbits. 
Because it was believed that these organisms were the same, they were 
grouped together under the name Bacterium septicemiae hemorrhagicae. 
Trevisan (1887), however, proposed that the organisms be considered as 
separate species with a common generic name, Pasteurella, in honor of 
Pasteur. Accordingly, Lignieres (1901) presented a system of classifi-
cation, earlier proposed by Flugge (1886), suggesting that the strains 
be named according to the animal species in which they caused disease, 
i.e., P. boviseptica, !..:._ aviseptica, !..:._ suiseptica, etc. 
Jones (1921) examined many organisms isolated from cattle with 
hemorrhagic septicemia and divided them into three groups which were 
distinguishable by agglutination reactions. Those which could hemolyze 
bovine and equine erythrocytes he called Bacillus bovisepticus Group 1 
(also called P. boviseptica by other workers). The bacteria in this 
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group were later given the name Pasteurella haemolytica by Newsom and 
Cross (1932) in reference to their hemolytic capability. Thus, R.:_ 
haemolytica was recognized as a separate entity from the organism which 
became known as Pasteurella multocida. An organism first called P. 
mastitidis (because it was repeatedly isolated from cases of mastitis 
in ewes) is now also included under the name R.:_ haemolytica. 
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It is now known.that~ haemolytica is involved as an etiologic 
agent of pneumonias in cattle, sheep, goats and swine, as well as 
septicemia of lambs and mastitis of ewes (Carter, 1968). Edwards (1959) 
reported the organism to be the cause of a septicemia in neonatal pigs 
and Maplesden and Carter (1955) reported it in a case of bovine mastitis. 
In addition, it has been implicated as a cause of central nervous 
system lesions in a calf (Goto and Itakura, 1975). In general, R.:_ 
haemolytica is not highly pathogenic for the species in which it is 
known to cause disease. This is attested to by the relatively high 
carrier rates found in healthy animals (Carter, 1968). It is also 
only mildly pathogenic or nonpathogenic for the common laboratory 
animals, including mice, rats, guinea pigs, rabbits, cats, and dogs. 
Elucidation of the different serologic types of~ haemolytica 
lagged far behind that for R.:_ multocida. Because many fresh R.:_ 
haemolytica isolates proved to be inagglutinable, Carter (1956a) 
decided to type the organisms by an indirect hemagglutination (IHA) 
technique which had been used successfully on R.:_ multocida in the early 
1950's. The IHA test utilized agglutination of erythrocytes to which 
were adsorbed specific lipopolysaccharide capsular substances from the 
organisms. Because all of the 61 bovine and ovine strains which Carter 
tested were found to be serologically homogeneous, he mistakenly assumed 
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that pathogenic strains were of the same serologic type. However, Smith 
(1959) examined the cultural, biochemical, and pathological character-
istics of strains of~ haemolytica isolated from cases of ovine 
pneumonia and divided them into 2 groups which he called biotype A and 
biotype T based on their ability to utilize arabinose or trehalose. 
Further studies using a modified IHA test on strains isolated from 
healthy and diseased cattle and sheep led Biberstein et al. (1960) to 
divide the species into 10 capsular serotypes designated by arabic 
numbers. Whereas all of the different serotypes were recovered from 
sheep, all but 2 of the bovine isolates tested were of type 1. One of 
the other bovine strains was of type 2 and the remaining isolate was 
untypable. The number of serotypes was later expanded to 12 and all 
12 types were grouped under Smith's A and T biotypes according to the 
following distribution (Biberstein and Gills, 1962; Biberstein and 
Thompson, 1966): 
Biotype A contains serotypes 1, 2, 5, 6, 7, 8, 9, 11, and 12 
Biotype T contains serotypes 3, 4, and 10 
Although the IHA test is both sensitive and specific for sero-
typing ~ haemolytica, it is labor intensive because antigens must be 
prepared from each culture to be tested and then adsorbed to erythro-
cytes. Therefore a rapid plate procedure for serotyping ~ haemolytica 
was developed by Frank and Wessman (1978). Their method can be 
performed in a matter of minutes using colonies grown on blood agar 
plates with essentially the same results as IHA testing. 
In addition to the typing systems mentioned, differences in 
cultures relating to their degree of encapsulation were noted. 
12 
Biberstein et al. (1958) observed two different types of colonies in each 
of three!...:_ haemolytica cultures isolated from lambs. The colonies 
differed in morphology, ability to take up crystal violet dye, adherence 
to the agar surface, and agglutinability. They determined that the basic 
difference between the two colony types was the amount of "surface 
substance" possessed and thus designated the variants S for smooth (with 
abundant surface substance) and R for rough (deficient in surface 
substance). 
Wessman (1964) studied broth cultures of the organism and found that 
both smooth and nonsmooth variants occurred within the population. He 
reported that, as the culture aged and the amount of available oxygen 
decreased, smooth cells died rapidly and "were replaced by nonsmooth 
variants" (Wessman, 1964, p. 356). He also noted a shift from smooth to 
nonsmooth organisms on agar slants stored at 5° C. Corstvet et al. 
(1982a) later reported that the majority of!...:_ haemolytica organisms are 
encapsulated in the early logarithmic phase of growth but that the 
capsular material appeared to be sloughed off the cells as the culture 
aged so that most stationary-phase organisms were no longer encapsulated. 
Perhaps the age-dependent nature of encapsulation explains the dissocia-
tion from smooth to nonsmooth organisms observed by Wessman (1964). An 
association between smoothness of cultures and virulence was also noted. 
Wessman (1964) found that the smooth variants in his broth cultures 
were more pathogenic for mice than were the rough variants, even though 
the two were indistinguishable in biochemical characteristics. Lilli 
(1977) also reported that it was the smooth colonial variant of P. 
haemolytica, serotype 1, which was almost always associated with bovine 
respiratory disease. 
Prevention of the Disease 
Control of pneumonic pasteurellosis of cattle depends upon 
(1) reduction in stress factors known to predispose animals to the 
disease, (2) reduction of exposure to infectious agents involved in 
the disease, and (3) immunological enhancement of resistance to the 
infectious agents. 
Control of stress factors may partially be achieved, even though 
transport of animals is a necessity. Dyer (1982) proposed several 
management practices designed to minimize stresses on beef cattle at 
the time of weaning, sale, and transport. Such "preconditioning 
programs" include weaning calves from dams at least one month prior to 
transport, early introduction to the post-transport diet, limiting 
transportation to the shortest possible distances, use of rest stops 
during which the animals have access to food and water, and planning of 
transportation times to avoid excessively inclement weather. 
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Reduction of exposure to infectious agents may depend primarily on 
minimizing the mixing of animals purchased from different sources for 
the first 45 days after arrival in a feedlot, during which time losses 
from respiratory disease are highest (Dyer, 1982). In addition to the 
social stress factor induced, mixing groups of cattle has been 
associated with widespread shedding and exchanging of viruses in the 
first 60 days post arrival at the feedlot (Irwin et al., 1979). Animals 
housed out-of-doors should be provided with some shelter from damp 
weather or excessive wind or sun. Indoor facilities should be equipped 
with_ proper air exchange systems to remove aerosols of pathogenic 
organisms shed by infected individuals, remove warm air containing 
excessive moisture, and allow for even, draft-free intake of fresh air 
(Dyer, 1982). 
Immunological enhancement of resistance to infectious agents has 
been achieved classically through the use of vaccines (containing live 
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or killed organisms), bacterins (containing killed organisms, by 
definition), or aggressins (crude supernatants from bacterial cultures). 
The earliest bacterins used against shipping fever were prepared from 
P. multocida only. Carter (1957), however, suggested that shipping 
fever bacterins should contain both R..!_ multocida and R..!_ haemolytic.a, 
type 1. He also stressed that only "freshly isolated capsulated 
cultures" and organisms harvested after short incubation periods (6-8 hr) 
should be used to favor "maximum antigenicity" (Carter, 1957). In 
several trials where Pasteurella bacterins were used, they were reported 
to have a protective effect against development of respiratory disease 
(Palotay et al., 1963; Hamdy and Trapp, 1964; Matsuoka et al., 1972; 
Morter et al., 1982). In general, however, use of Pasteurella bacterins 
in controlled studies has not proved efficacious. It was reported in 
two early studies that Pasteurella aggressins provided better protection 
for cattle than did bacterins (Buckley and Gochenour, 1924; Miller, 1927). 
In another study, a dramatic increase in mortality rates of animals 
given either aggressin or bacterin, or both preparations in combination 
was reported (Farley, 1932). In later studies also, bacterin-
vaccinated or bacterin plus vir~s-vaccinated animals were shown to have 
equal or greater death losses, weight losses or disease prevalence than 
control animals (Hamdy et al., 1965; Woods et al., 1974; Friend et al., 
1977; Martin et al., 1980; Amstutz et al., 1981; Bennett, 1982). 
Wilkie et.al. (1980) vaccinated calves either intrabronchially or 
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subcutaneously with formalin-killed R..:_ haemolytica and then challenged 
the calves with live R..:_ haemolytica intrabronchially. They found that 
after challenge, respiratory rates and macroscopic pulmonary lesions 
were greater in calves vaccinated subcutaneously than in control animals. 
Inununization by the intrabronchial route was not associated with adverse 
effects and was thought to provide a moderate degree of protection. 
Those investigators theorized that parenteral inununization with the 
killed organism promoted production of IgG antibodies which were opsonic 
and therefore enhancedphagocytosis by macrophages. The same group had 
previously shown (Markham and Wilkie, 1980) increased phagocytosis to 
be detrimental to phagocytes. They felt that intrabronchial inununiza-
tion, however, stimulated a non-opsonic IgA response that was mildly 
protective and not deleterious to the macrophages. Another theory on 
failure of bacterins to provide effective protection against shipping 
fever is that parenteral exposure to killed organisms may fail to 
generate antibody capable of neutralizing R.:._ haemolytica cytotoxin 
(Dyer, 1982). Review of data such as these on the use of bacterins 
may be sununed up by Wilkie's (1981) statement that 
In view of the historically extensive use of these bacterins, 
the continued high prevalence of fibrinous pneumonia with 
isolation of R..:_ haemolytica and the known potential of 
vaccination as a general procedure to very successfully 
protect against several important veterinary diseases, it 
seems safe to assume that Pasteurella bacterins do not 
have obvious usefulness in control of shipping fever (p. 113). 
In recent years, attention has been turned toward other types of 
Pasteurella vaccines. Potassium thiocyanate or sodium salicylate 
capsular extracts from R..:_ haemolytica have been shown to be protective 
against experimental pneumonia in both sheep (Gilmour et al., 1983; 
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Mukkur et al., 1983) and cattle (Yates et al., 1983). Other studies have 
shown that cytotoxin preparations from the organism are antigenic for 
rabbits (Shewen and Wilkie, 1983a) and cattle (Baluyut et al., 1981; 
Opuda-Asibo et al., 1983). In a study of sera obtained from beef cattle 
at necropsy, the cytotoxin-neutralizing activity was significantly lower 
for sera from calves dying of fibrinous pneumonia than from calves dying 
for reasons other than pneumonia (Shewen and Wilkie, 1983b). Gentry and 
Confer (1983) also showed that the cytotoxin-neutralizing capacity of 
serum from calves unexposed, naturally exposed, or exposed by vaccination 
to live~ haemolytica was significantly correlated to ability of the 
calves to resist an experimental R.:_ haemolytica challenge. These results 
indicate that induction of the ability to neutralize!'...:._ haemolytica 
cytotoxin may be an important part of an effective immunization program 
against pneumonic pasteurellosis. 
Immunization with live~ haemolytica, either parenterally or by 
aerosnl, has been shown recently to enhance resistance to a trans-
thoracic, intrapulmonic challenge with the organism (Corstvet et al., 
1978; Confer et al., 1984a; Panciera et al., 1984). In a subsequent 
series of comparative studies, live vaccines were consistently more 
effective than bacterins in enhancing resistance to experimentally-
induced disease (Confer et al., 1984b). The superiority of immunizing 
capacity of live compared to killed organisms may result from the 
multiplication of live bacteria in the host.· Live preparations would 
be more likely to present the immune system with antigens, such as 
those found in capsular material or cytotoxin, which may be absent or 
altered in killed preparations. Future immunization attempts should 
thus utilize live organisms or antigen preparations from them. 
Interactions of Gram Negative Bacteria with 
Mammalian Serum Factors 
The capacity to kill gram negative bacteria is associated with 
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serum from a variety of warm-blooded and cold-blooded animals, including 
fish (Taylor, 1983). Killing of susceptible bacteria is mediated by 
complement which may be activated by either the classical or alternate 
pathway (Taylor and Kroll, 1983). Classical complement activation is 
generally accomplished by the interaction of antibody and surface 
antigens on the organisms (Atkinson and Frank, 1980). The classical 
pathway may also be activated directly by the lipid A region of lipopoly-
saccharide (Loos et al., 1978), but lipid A is normally not exposed on 
the surface of gram negative bacteria. The alternate pathway is antibody 
independent and may be activated by a number of surface structures found 
on bacteria, such as cell walls and lipopolysaccharides, as well as by 
aggregated immunoglobulins (Atkinson and Frank, 1980). Activation of 
complement by either pathway eventually leads to deposition on the 
cytoplasmic membrane of complement factors C5b-C9. This aggregate, 
called the membrane attack complex, is responsible for the irreversible 
damage that causes death of the organism (Taylor and Kroll, 1983). 
Bacteriolysis, when it occurs, is carried out by lysozyme. However, 
lysozyme bacteriolysis can only occur after the membrane attack complex 
has been integrated into and has destroyed the integrity of the cell 
membrane (Taylor, 1983). 
When antibody-mediated activation of complement occurs, extremely 
small amounts of antibody are required, making the bactericidal reaction 
much more sensitive for determining the presence of antibody than the 
agglutination reaction (Taylor, 1983). lgM is more efficient at 
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activating complement by the classical pathway than is IgG because one 
molecule of IgM is sufficient to activate one molecule of the Clq 
component of Cl, whereas two molecules of IgG are necessary and they 
must be bound in close proximity (Taylor, 1983). Certain IgG subclasses 
(depending on the species of animal examined) are not capable of acti-
vating complement to a significant extent. IgA is not only thought to 
be inactive in the bactericidal reaction, but is known to inhibit the 
bactericidal effect of IgM and IgG in certain cases, presumably by 
binding to available antigenic sites in a competitive blocking reaction 
(Rowley, 1973). 
Certain bacteria are able to resist the bactericidal action of 
serum. To date there is no evidence that such organisms are resistant 
because of an ability to produce extracellular products that neutralize 
or destroy the functional integrity of the complement components (Taylor, 
1983). There is evidence that the outer cell membrane is involved in 
the serum resistance of some gram negative organisms. Pretreatment of 
serum resistant cells with Tris and EDTA, which releases much of the 
lipopolysaccharide complexed to the outer membrane and also lowers its 
permeability barrier, has been shown to increase the sensitivity of 
the cells to serum bactericidal action (Reynolds and Pruul, 1971). 
Treatment of certain serum-resistant enterobacteria to Polymyxin B, 
which adversely affects the integrity of the outer membrane, is also 
known to cause the organisms to become serum sensitive (Fierer and 
Finley, 1979). Taylor (1983) proposed that 
.•• serum resistance does not result from a block in the 
activation of the complement cascade. Rather, MAC's 
[membrane attack complexes] formed on the surfaces of serum-
resistant strains are not effectively inserted into the 
bacterial membranes and are released without causing lethal 
damage (p. 63). 
Smooth strains of gram negative bacteria possessing lipopoly-
saccharide with core units highly substituted by O antigen side chains 
are generally found to be more resistant to serum killing than rough 
strains lacking the O antigen component of lipopolysacchqride (Rowley, 
1968; Reynolds and Pruul, 1971; Taylor, 1975). It has been proposed 
that the serum resistance of smooth strains is due to interference by 
the O antigen polysaccharides with the formation, attachment, or 
subsequent activity of the membrane attack complex (Taylor, 1983). 
It has frequently been observed that bacteria in the logarithmic 
phase of growth are more sensitive to serum killing than are those in 
the lag or stationary phases (Davis and Wedgwood, 1965; Rowley, 1973; 
Taylor and Kroll, 1983). Rowley (1971) proposed that the increased 
sensitivity of rapidly dividing organisms could be due to an inability 
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of sugar transferases, which link together the repeating oligosaccharide 
units of the smooth O antigens, to keep pace with cell wall production. 
Such cells would have exposed areas of rough polysaccharide unprotected 
by the smooth O antigen. Another theory is that a certain amount of 
cellular biosynthetic activity or energy is necessary for serum killing, 
and lag- or stptionary-phase cells are not as metabolically capable 
of producing the needed components (Taylor and Kroll, 1983). 
Some differences in sensitivity of gram negative bacteria to the 
bactericidal effects of serum have been shown to depend on environ-
mental conditions and the metabolic state of the organisms being tested. 
The antigenic composition of a bacterial culture varies greatly 
depending on the environmental conditions imposed, including temperature 
and availability of oxygen, nutrients, energy sources, etc. Phenotypic 
variations due to culture conditions thus can affect the serum sensi-
tivity of an organism by influencing the biosynthesis of cell surface 
structures and the metabolic state of the cells (Taylor, 1983). 
The importance of temperature regulation in serum bactericidal 
assays has been reported (Osawa and Muschel, 1964). Temperatures at or 
near optimum for bacterial growth should be used because suboptimal or 
elevated temperatures can cause reductions in killing rates (Kato and 
Bito, 1978). Those authors hypothesized that membrane fluidity, 
permitting a high degree of molecular motion, is obligatory to the 
efficient bactericidal action of complement. 
Composition of the growth medium has also been shown to affect the 
serum sensitivity of bacterial cultures. A strain of Escherichia coli 
was demonstrated to be more susceptible to serum killing when grown in 
a simple salts medium than in a medium which was nutritionally complex, 
even when the growth rates were identical (Melching and Vas, 1971). 
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The authors postulated that the difference might be related to a greater 
ability of the cells grown in the complex medium to repair complement-
mediated damage to their membranes. Similarly, Salmonella typhimurium 
grown in diluted broth was found to be more sensitive than when it was 
grown in undiluted broth to killing by human serum (Maal~e, 1948). 
Because bacterial species demonstrate a wide array of biochemical 
and physiological requirements, there is no widely accepted standard 
assay for serum bactericidal activity. Thus, it is important for investi-
gators to standardize conditions used in their experiments and to 
explicitly describe their methods when reporting results. Serum 
sensitivity measurements are generally made by incubating organisms 
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with a suitable concentration of serum, with or without the addition of 
an exogenous complement source, and determining the change in the number 
of live organisms by a colony counting technique after certain time 
intervals. Viable colony counting techniques are well known for pro-
ducing results with high standard deviations, leading investigators to 
adopt multiple sampling methods which are time consuming and laborious. 
Muschel and Treffers (1956) thus developed an alternative assay based on 
an increase in optical density due to regrowth of surviving organisms 
after their removal from the conditions of the bactericidal assay. 
However, a comparison of this method with a conventional plating 
technique revealed a consistently lower number of survivors as 
determined by the former than by the latter method, suggesting that a 
temporary lag in cell division occurred in the photometric assay 
(Michael and Braun, 1964). Other rapid assay systems have been 
developed, including a plaque assay which involves spotting serum 
dilutions on a plate streaked for confluent growth (Fierer et al., 
1972), an assay based on loss of ability to synthesize protein (Kato 
and Bito, 1978), a radioassay to determine release of 51cr-labelled 
lipopolysaccharide (Fierer et al., 1974), and a radioactively-labelled 
DNA release method (Friedlander, 1975). 
Phagocytosis and Intracellular Killing of 
Bacteria by Phagocytes 
Metchnikoff (1887) was the first to publish the theory that 
bacteria could be destroyed within a host by phagocytes. The prevailing 
theory at that time was that resistance to bacterial infections depended 
entirely upon humoral factors in the serum, leading to a major controversy 
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between the humoral versus cellular theories of immunity (Wood, 1960). 
The two factions were somewhat reconciled by the discovery that anti-
bodies and phagocytes could work together in destroying bacteria. Wright 
and Douglas (1903) called the serum factors that assisted in phagocytosis 
"opsonins" from the Greek meaning "to prepare for dining." Later 
investigations revealed that fresh normal or preimmune serum has opsonic 
power that could be destroyed by heat, whereas serum from immunized 
animals contained heat-stable opsonic factors (Mudd et al., 1934). In 
addition, it was shown that in some instances, the heat-labile and 
heat-stable serum factors could work cooperatively (Ward and Enders, 
1933). 
The two types of phagocytes that defend against microbial infections 
are polymorphonuclear leukocytes (PMN) and mononuclear phagocytes 
(peripheral blood monocytes and tissue macrophages). PMN are thought 
to be primarily responsible for defense against extracellular, invasive 
organisms which tend to cause acute infections. Mononuclear phagocytes, 
on the other hand, are more important in defense against facultative or 
obligate intracellular organisms which tend to cause chronic infections 
(Cline and Territo, 1980). Organisms that resist intracellular killing 
by phagocytes can actually be transported in them to sites distant from 
the primary focus of infection. Mononuclear phagocytes generally 
respond to more lightly opsonized bac.teria than do PMN (Stossel, 1975). 
However, they are less efficient than PMN at killing conventional 
microorganisms (Densen and Mandell, 1980). 
The first step in the phagocytic process involves formation of a 
stable bond between the phagocyte and the organism. This may be 
accomplished inefficiently by chance contact in a fluid medium or 
somewhat more efficiently by what Wood (1960) termed "surface phago-
cytosis." This term refers to the ability of phagocytes to trap 
organisms against the surfaces of tissues or against each other's 
surfaces when the cells are packed closely together in thick exudates. 
Opsonization of bacteria by antibody provides a more efficient method 
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of bond formation. Antibody can act as a bifunctional molecule which 
binds to bacteria by its Fab region and then activates ingestion through 
the Fe region (Stossel, 1975). This action is implied by the observation 
that papa'in- or pepsin-digested antibody, containing Fab fragments only, 
will bind to bacteria but does not opsonize them (Quie et al., 1968). 
Microorganisms may also be opsonized by the sequential interaction of 
antibody and the classical components of complement: Cl, C4, C2 and 
then C3; or by deposition of C3b on the organism through the alternate 
complement pathway in the absence of antibody (Stossel, 1975). 
Opsonization thus involves deposition of antibody and/or complement on 
the surface of an organism, leaving the Fe fragments of the antibody 
molecules and the C3b fragments of complement exposed to react with 
specific plasma membrane receptors found on phagocytes (Wilkinson et al., 
1979a). Polymorphonuclear leukocytes contain receptors only for the Fe 
portion of IgG, so opsonization of bacteria by other classes of 
immunoglobulin does not promote ingestion by those cells (Densen and 
Mandell, 1980). 
Opsonization also is thought to have another mode of action. 
Normally, both phagocytes and organisms have a negative surface charge 
which leads to an electrostatic repulsion between the two cell types. 
Opsonization results in an increased hydrophobicity of organisms and a 
reduction in the charge repulsion between them and adjacent phagocytes 
(,ran Oss, 1978; Winter, 1979). 
Once a bond between the phagocyte and the organism has been 
established, the actual process of phagocytosis begins. Adherence 
stimulates local cell membrane activity so that a pseudopod is formed 
which flows around the organism, engulfs it, and then fuses to leave 
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the particle enclosed in a membrane-lined vacuole, a phagosome. Griffin 
and coworkers (1976) demonstrated with macrophages that opsonic binding 
of phagocytes to particles was not necessarily followed by ingestion. 
They found that ingestion required homogeneous distribution of opsonins 
over the entire surface of the particle as well as receptors over the 
surface of the macrophage membrane. The cellular events occurring after 
ingestion which lead to intracellular killing and degradation of 
phagocytized organisms have been reviewed recently (Elsbach, 1980), and 
will not be included here. 
Intact organisms are generally not susceptible to the action of 
degradative enzymes; therefore digestion of engulfed organisms is, to a 
large extent, determined by the cell envelope protecting the organisms 
and the ability of the phagocyte to degrade or penetrate the envelope. 
Many gram positive bacteria with relatively simple envelopes are more 
easily and more rapidly degraded than gram negative organisms that are 
protected by an envelope containing an additional outer membrane 
(Elsbach, 1980). Escherichia coli has been shown to become more 
sensitive to lysosomal degradation after boiling (Cohn, 1963) and 
after induction of spheroplast formation (Patriarca et al., 1972). 
Bacterial degradation does not necessarily have to occur for killing 
of the organisms to take place. PMN have been shown to kill> 95% of an 
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.§...=._ coli population (as determined by an inability to multiply) within 
15 min after ingestion. The organisms did not, however, show major 
structural and functional disorganization (Elsbach, 1980). Nevertheless, 
ingested.§...=._ coli rapidly develop increased membrane permeability, as 
demonstrated by entry of Actinomycin D into bacteria which would 
normally be impermeable to that antibiotic (Leive, 1974). 
Testing of phagocytic capacity in vitro requires attention to 
details of cultural conditions much like the testing of serum bacteri-
cidal activity mentioned above. Pseudomonas cepacia grown in batch 
culture under conditions of specific nutrient depletions showed varying 
degrees of sensitivity to engulfment and killing by human PMN (Anwar 
et al., 1983). Similarly, Finch and Brown (1978) used chemostat-grown 
organisms and reported that slow-growing magnesium-limited cells of 
Pseudomonas aeruginosa were significantly more resistant to the lethal 
effects of rabbit PMN than were either fast-growing magnesium-limited 
cells or slow-growing carbon-limited cells. Those investigators 
hypothesized that the differences in sensitivity of organisms grown 
under various conditions reflect phenotypic variations in their cell 
envelope composition. Such variations could lead to changes in the 
surface free energy of the cells or alterations in sensitivity to 
opsonization. 
The growth phase of the organisms tested also has been shown to 
have an effect on phagocytosis of microorganisms. Mezzatesta and Rest 
(1983) found that human blood monocytes were able to kill stationary-
phase Neisseria gonorrhoeae but could not kill log-phase organisms. 
Whitnack et al. (1981), utilizing a system in which binding of organisms 
to macrophages could occur but internalization could not, found that 
attachment of early log-phase Group A Streptococcus was low, whereas 
attachment was high for organisms in late log phase and thereafter. 
Phagocytosis and killing as measured in vitro may depend on the 
incubation temperature used. An increased bactericidal capacity of 
human PMN incubated at 40° C compared with those maintained at 37° C 
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was observed with.!:._ coli,~ typhimurium, and Listeria monocytogenes, 
but not with Staphylococcus aureus (Mandell, 1975; Roberts and 
Steigbigel, 1977). Anwar et al. (1983) similarly found that exponential-
phase cells of.!:!_ cepacia exposed to human PMN had a consistent decrease 
in survival as the incubation temperature of the phagocytes was increased 
from 33° C to 41° C. 
The earliest studies of phagocytosis were performed by light 
microscopic examination of fixed smears of phagocytes after ingestion 
of bacteria. It was realized, however, that it is often difficult to 
differentiate between non-specific attachment of organisms to phagocytes 
and actual internalization of bacteria (Mudd, 1934; Finch and Brown, 
1978). Techniques in electron microscopy have also been used to 
demonstrate internalization of organisms and other cells within 
membrane-bound vacuoles of phagocytes (Chambers, 1973; Maheswaran et al., 
1980). 
Indirect assays of phagocytosis utilize indicators such as reduction 
in viability of phagocytized organisms or metabolic stimulation of 
phagocytes after ingestion of organisms. The bactericidal assay 
measures a decrease, over time, in the viable count of a mixture of 
phagocytes and bacteria; interpretation of results assumes that 
phagocytized organisms have been killed. The limitations of this 
app~oach include its laboriousness and its inability to discriminate 
between changes in viable counts due to phagocytosis and those due to 
other factors. Growth of unphagocytized organisms or agglutination of 
bacteria, which may occur over the relatively long incubation times 
required, can lead to misinterpretation of results (Stossel, 1975). 
The use of metabolic indicators of ingestion by phagocytes, such as the 
rate of glucose oxidation to co2 or reduction of nitroblue tetrazolium, 
has an advantage of allowing measurement without prior separation of 
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the phagocytes from unphagocytized organisms. However, the metabolic 
activity of resting cells contributes background activity, and increased 
cellular metabolism has been shown to be stimulated by the components 
of certain organisms without actual particle uptake (Cohn and Morse, 
1960). 
Perhaps the most theoretically sound methods for assay of ingestion 
involve direct determination of the number of organisms within phagocytes. 
This may be done by radioactively labelling the organisms and measuring 
phagocyte-associated radioactivity (Verhoef et al., 1977; Hof et al., 
1980) or by determining the number of viable organisms within phagocytes 
after short incubation periods (van Furth and van Zwet, 1973; Rush et al., 
1981). The major technical problem in conducting these assays is that 
extracellular organisms must be removed from the reaction mixture before 
measurement of cell-associated organisms is made. Separation is 
usually accomplished by extensive washing of phagocytes which have been 
attached to glass or plastic surfaces in monolayers (Campbell et al., 
1983) or by differential centrifugation of cells and bacteria in 
suspension (Verhoef et al., 1977; Rush et al., 1981). Neither of these 
methods can adequately remove organisms that are bound to the surface 
of phagocytes but are not actually internalized. 
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When both intracellular killing and phagocytosis are to be measured, 
viable counting techniques are generally used. An additional problem 
encountered with these techniques is growth of unphagocytized organisms. 
Multiplication of extracellular organisms can invalidate mathematical 
calculations of phagocytosis made from viable counts of supernatant 
samples, and also can be misinterpreted in intracellular killing assays 
as intracellular multiplication. To circumvent these problems, several 
investigators have added antibiotics to suspensions of phagocytes after 
separation from unphagocytized organisms (Kapral and Shayegani, 1959; 
Alexander and Good, 1968; Hsu and Radcliffe, 1968). Other groups have 
argued that antibiotics can penetrate phagocytes (Cole and Brostoff, 
1975). Rhodes and Hsu (1974) therefore incorporated antiserum instead 
of antibiotics to control the growth of extracellular organisms. An 
additional method for determining intracellular killing has been 
developed, based on the assumption that release of DNA from organisms 
can be taken as direct evidence of cell death (Friedlander, 1978; 
Davies, 1982). In this method, the amount of radioactivity released 
from organisms that have been phagocytized is measured. Measurement 
by this technique is not obscured by growth of extracellular organisms 
and is absolutely specific for organism death, but it may lack 
sensitivity for certain organisms that resist the extensive degradation 
necessary for bacterial DNA to be released. 
Roles of Capsular Material in the Pathogenesis 
of Selected Organisms 
Bacterial exopolysaccharides are a complex group of polymers which 
are generally formed from repeating units of 2-6 monosaccharide residues 
assembled by membrane-bound enzymes and are then extruded from the cell 
surface (Sutherland, 1972). They may then form a slime layer which is 
apparently unattached to the bac.terial cell or a discrete capsule 
attached by some unknown mechanism to the outer layer of the cell wall. 
The fact that nonmucoid variants of normally encapsulat~d organisms are 
frequently found in the laboratory plus the knowledge that capsules 
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can be removed physically or enzymatically without killing the organisms, 
would indicate that exopolysaccharides are not essential for the growth 
and survival of the bacteria on which they are found. However, other 
observations point to their importance to the organisms. Certain 
bacteria, such as Klebsiella aerogenes and Streptococcus pneumoniae, 
are almost always mucoid when isolated from a host animal. They often 
will become nonmucoid after repeated transfer in artificial media in 
which the nonmucoid form grows as well or better. This suggests that 
some factor in the normal host environment favors the selection of 
mucoid variants (Wilkinson, 1958). 
The association found in many pathogenic organisms between degree 
of encapsulation and increased virulence is another indication that 
capsular material is of value to certain organisms (Smith, 1977; Densen 
and Mandell, 1980; Tajima et al., 1982). Pathogenicity refers to the 
ability of microorganisms to produce disease in a host. As stated by 
Smith (1977, p. 476), "Whether, in a particular instance, disease 
occurs or is prevented depends on the outcome of interactions between 
the microbe and the host." The majority of such interactions involve 
the surface of the organ.ism with host defense mechanisms, including 
adherence of the organism to host epithelial surfaces, degree of 
microbial resistance to humoral antibodies and other antimicrobial 
substances, and degree of resistance to ingestion and intracellular 
killing by host phagocytes. Thus any surface component, including 
capsular material, which renders an organism more resistant to host 
defenses must be considered as a potentiator of pathogenicity, and 
thus a virulence factor. 
Specific interactions between surface components of bacteria and 
host mucosal surfaces are responsible for determining which organisms, 
whether pathogens or commensals, will selectively adhere to certain 
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host surfaces. For example, the K88 capsular antigen on the surface of 
_!:._ coli strains that are enteropathogenic for piglets is considered to 
be a virulence factor because it determines the ability of the organisms 
to attach to the brush border of the upper small intestine (Smith, 1977). 
_!:._ coli strains lacking the K88 antigen do not attach and are avirulent. 
By the same token, piglets genetically deficient in the epithelial 
receptor for the K88 antigen are naturally resistant to the disease. 
Capsular material of Mycoplasma gallisepticum, a cause of respiratory 
disease in chickens and turkeys, has also been implicated as a virulence 
factor because of its association with the adhesive properties of the 
organism to avian tracheal epithelial cells (Tajima et al., 1982). 
The presence of capsular material on the surface of certain 
bacteria has been shown to render the organisms resistant to aggluti-
nation by normal serum and by serum containing antibodies specific for 
somatic O antigens. Muschel et al. (1958) found a marked correlation 
between the capsular content of several Salmonella typhi strains and 
their inagglutinability with anti-0 antiserum. Extracts of capsular 
material from gram negative bacteria have also been shown to inhibit 
agglutination in serologically unrelated systems. For example, extracts 
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of capsular K antigens from!.!._ coli were shown to quantitatively inhibit 
agglutination of sheep erythrocytes by rabbit anti-sheep serum (Glynn 
and Howard, 1970). Ceppellini and Landy (1963) suggested that the 
ability of K antigens to suppress agglutination was related to their 
viscosity. Others have related it to their large negative charge 
(Wilkinson, 1958), or to inhibition of lattice for~ation between 
adjacent bacteria (Glynn and Howard, 1970). 
Capsular material has also been shown to protect certain gram 
negative bacteria from the bactericidal effects of serum. The capsular 
K antigen of!..=._ aerogenes, an opportunistic pathogen of debilitated 
humans, was found to be involved in determining the resistance of the 
organism to complement-mediated serum killing (Williams et al., 1983). 
Strains of encapsulated organisms were resistant to normal human serum 
but nonencapsulated organisms were serum sensitive. Furthermore, 
resistant strains are frequently isolated as the causative agents of 
infections involving tissue damage, leading to the suggestion that 
serum resistance is an important determinant of virulence in at least 
some infections due to gram negative bacteria (Taylor, 1983). 
Chelation of the serum with Mg-EGTA to prevent activation of the 
classical complement pathway delayed the rapid serum killing of non-
encapsulated organisms by approximately 15 min. In another system, 
fresh preimmune rabbit serum without demonstrable antibodies was 
bactericidal for two nonencapsulated strains of Haemophilus· influenzae, 
whereas two encapsulated strains were resistant to the same serum 
(Branefors and Dahlberg, 1980). Heat treatment of the serum at 56° C 
for 5 min destroyed the bactericidal effect. Hyperimmune rabbit serum 
was bactericidal for both encapsulated and nonencapsulated strains, 
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even after heating at 56° C for 30 min. It was proposed by ·those 
investigators that encapsulated.!!.:_ influenzae lacked the ability to 
activate complement through the alternate pathway, even though they were 
very sensitive to complement activated through the classical pathway. 
Capsular K antigens have also been shown to influence the. sensitivity 
of~ coli strains to complement-mediated killing (Glynn and Howard, 
1970). Complement resistance in 4 strains was proportional to their 
K antigen content as measured by immunodiffusion. In addition, the 
strains became more sensitive to complement when the organisms were 
grown at non-optimal temperatures at which a reduced amount of K antigen 
was produced. 
The mechanism by which the presence of capsular substances render 
organisms more resistant to serum bactericidal effects is not clearly 
understood. Surface structures have been thought to cause activation 
of complement at so great a distance from the cytoplasmic membrane that 
the intermediates decay before they can be incorporated into functional 
membrane attack complexes (Rowley, 1973). It has also been suggested 
that capsular material and long O side chains on lipopolysaccharide of 
smooth organisms may impede antibody binding and subsequent attachment 
of complement components to the surface of the organisms (Glynn and 
Howard, 1970). However, other evidence suggests that polysaccharide 
capsules do not act as diffusion or permeability barriers to macro-
molecules such as IgG, certain complement components, and lysostaphin 
(King et al., 1980; Kirig and Wilkinson, 1981). Still other evidence 
exists which would indicate that capsular material does not necessarily 
confer serum resistance on organisms. For instance, most Klebsiella 
strains produce abundant capsular material, but many of them are also 
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susceptible to the bactericidal effects of serum (Fierer et al., 1972). 
In addition, _the isolates of~ aeruginosa recovered from patients with 
cystic fibrosis are generally extremely mucoid, but they also are 
frequently more susceptible to serum killing than are strains of the 
organism isolated from other sources (Taylor, 1983). Such epidemio-
logical comparisons make it very difficult to propose a general mechanism 
for the role of capsular material in serum resistance of gram negative 
organisms. 
Perhaps the most important function of capsular material in the 
pathogenesis of bacteria is that of protection against phagocytosis. 
As stated by Wilkinson (1958, p. 66), "Although there are probably many 
factors which cause resistance of a microorganism to phagocytosis, it 
is clear that one of the most important is the presence of a capsular 
polysaccharide." Among the organisms possessing capsules that prevent 
ingestion by phagocytes are Streptococcus pneumoniae, Streptococcus 
pyogenes, Neisseria gonorrhoeae, Neisseria meningitidis, !.!._ pneumoniae, 
~ aureus, H. influenzea Group B, ~ coli, Yersinia pestis, Bacillus 
anthrasis, Campylobacter fetus, Bacteroides fragilis, and~ multocida 
(Densen and Mandell, 1980). A clear correlation between capsule-induced 
resistance to phagocytosis and virulence is shown with Yersinia pestis 
which only acquires capsules after it has infected a host (Densen and 
Mandell, 1980). Those organisms are transmitted by fleas and exist in 
the flea in a nonencapsulated state. When the organisms are trans-
ferred through the flea bite to a mammalian host, they are rapidly 
phagocytized and killed by PMN. Those phagocytized by monocytes, 
however, remain viable, multiply within the monocytes, and acquire 
capsules. Upon death of the monocytes, encapsulated organisms are 
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released that are resistant to phagocytosis by both neutrophils and 
monocytes. They continue to multiply, producing the symptoms of plague 
(Cavanaugh and Randall, 1959). 
There are many other examples of organisms which are more resistant 
to phagocytosis when encapsulated than when nonencapsulated because of 
mutations or unfavorable growth conditions. Encapsulated organisms 
have also been shown to be more resistant to phagocytosis than those 
decapsulated by chemical or physical means. Many of the earliest studies 
of encapsulated organisms were performed with the pneumococcus with 
which a clear correlation was found between the mucoid nature of colony 
(indicating degree of encapsulation), virulence, and resistance to 
phagocytosis (Wilkinson, 1958). Fresh, encapsulated clinical isolates 
of S. aureus also were found to be more resistant to phagocytosis by 
human PMN than were the same strains after repeated subculturing on 
artificial media, whereby they reverted to nonencapsulated types 
(Karakawa and Young, 1979). The laboratory-propagated strains also 
were found to be less virulent for mice than were the parent strains. 
The same investigators found that phagocytosis of nonencapsulated 
strains by PMN occurred readily in the presence of either normal or 
immune serum, whereas phagocytosis of encapsulated strains required 
the presence of specific homologous antiserum. Encapsulated strains of 
E. coli also were found to be more resistant than nonencapsulated strains 
to phagocytosis and killing by bovine PMN, requiring approximately 
100 times more serum opsonins that the nonencapsulated strains (Hill 
et al., 1983). Williams et al. (1983) studied another gram negative 
organism,!..=._ aerogenes. They found that in the absence of specific 
antiserum, two encapsulated strains were not ingested to any appreciable 
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extent by PMN in whole human blood. Addition of homologous anti-capsular 
serum to the bacteria resulted in a dramatic increase in phagocytic 
ingestion. Antiserum made to a smooth but nonencapsulated strain 
(anti-0 serum) also effectively opsonized one of the encapsulated 
strains, but it failed to opsonize the second encapsulated strain unless 
the amount of capsular material surrounding the cell was physically 
reduced. 
Although it has been agreed for many years that the presence of 
capsular material causes bacteria to be more resistant to phagocytosis, 
the mechanism for such resistance has not been clearly understood., 
In 1945, Dubos stated that encapsulated pneumococci maintained a 
definite distance from leukocytes by a sort of negative chemotactic 
effect, presumed to be due to a repulsion between the hydrophilic 
capsule and the hydrophobic phagocyte surface, or to a repulsion between 
the negative charges on the two cell surfaces (Wilkinson, 1958). It 
was thought, then, that anti-capsular antibodies opsonized by combining 
with the surface layer of the capsule, thereby reducing its hydrophobic 
character and its negative charge. However, other investigators of the 
time produced evidence to the contrary. Rothbard (1948) found that a 
group A streptococcus, which possessed a hyaluronic acid capsule 
impregnated with a protein component called M protein, was a million 
times more virulent than the corresponding variants possessing capsules 
without M protein. The M protein should, according to the prevailing 
theory, have acted much like an antibody, reducing the negative charge 
and hydrophilicity of the capsule and making the organisms more 
sensitive to phagocytosis and thus less virulent. 
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In other attempts to elucidate the mechanisms of capsule-induced 
resistance to phagocytosis, the size of capsules was correlated with 
degree of resistance conferred. Wood and Smith (1949) found that the 
high resistance to surface phagocytbsis of type 3 ~ pneumoniae compared 
to other pneumococcal types, was due to the possession of a larger 
capsule. Another group of investigators working with the same organism 
reported that the different susceptibilities to phagocytosis among 
strains was due to differences in the chemical composition of the 
capsules (MacLeod and Krauss, 1950). However, they also reported that 
resistance by mutants of a given capsular type correlated directly 
with the amount of capsular material each produced. Similarly, Melly 
et al. (1974) demonstrated a direct correlation between the capsule 
size of S. aureus strain Mand its resistance to phagocytosis by PMN. 
Still, factors other than capsule size have to be important because 
group A streptococci which had been decapsulated with hyaluronidase, 
were still found to be engulfed only slowly by leukocytes and to be 
highly virulent (Rothbard, 1948). Such inconsistencies led Wilkinson 
(1958·, p. 67), to state, "It is also possible that an important factor 
in governing phagocytosis is the sensitization of the bacterial surface 
by a substance present in nonimmune serum. Extracellular polysaccarides 
may prevent this combination." 
Within the last 10 years, the importance of the "substance present 
in nonimmune serum" that Wilkinson alluded to has been shown to be 
complement. Complement is deposited on the surface of bacteria after 
activation of the classical pathway by antibody deposition on the 
organism, or by the alternate pathway in the absence of antibody (see 
section on Phagocytosis). Most organisms are known to be opsonized, as 
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long as they are not in an encapsulated state, by complement alone or by 
complement plus antibodies found in many normal sera to their major cell 
wall components (Densen and Mandell, 1980). There are two possible 
explanations for the failure of encapsulated organisms to be opsonized 
by normal serum or by serum with antibodies to cell wall, but not 
capsular antigens. Capsular material could either block the binding 
of opsonins to the organism or mask opsonins that are bound to the 
surface of an organism, preventing the opsonins from acting as ligands 
between the organism and the phagocyte. Experimental evidence has 
since been obtained which supports both of these hypotheses. 
In a study supporting the hypothesis that capsular material blocks 
binding of opsonins to the surface of the organism, Stinson and van Oss 
(1971) performed adsorption studies with 
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I-labelled IgG and 
s. aureus. They found that encapsulated organisms adsorbed 70% more 
protein than did heat-treated, decapsulated organisms, and more than 
twice as much as did a nonencapsulated strain. They felt these results 
suggested that a certain quantity of the IgG was physically trapped 
within the capsule matrix. Horwitz and Silverstein (1980) also presented 
evidence supporting this theory. They found that P}1N phagocytized and 
killed encapsulated.!=._ coli only in the presence of complement and 
antibacterial antibody, whereas they phagocytized and killed a non-
encapsulated mutant of the same strain in the present of complement 
alone. They further demonstrated by fluorescence microscopy that 
antibody had to be present for encapsulated, but not nonencapsulated, 
organisms to fix complement to their surface. They concluded that in 
the absence of antibody, the.!.:__ coli capsule blocks complement fixation 
to the bacterial surface, probably by covering surface lipopolysaccharide 
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capable of activating complement in the absence of antibody. In another 
study in which 21 strains of several bacterial species were used, 
Verbrugh et al. (1979) used a quantitative fluorescent innnunoassay to 
measure the amount of the C3 component of complement bound to the 
surface of bacteria. They found that encapsulated strains of E.!.. aureus, 
!..!_coli,!.!_ pneumoniae, and E.!.. typhi failed to bind significant amounts 
of C3 in noninnnune human serum and were also inefficiently phagocytized 
by human PMN. Nonencapsulated strains of!..!_ coli and S. aureus were 
found to fix C3 readily and to be efficiently phagocytized. They 
concluded that "encapsulation interferes with the process of complement-
dependent opsonization due to masking by the capsule of other, complement-
activating, cell wall components (Verbrugh et al., 1979, p. 813). 
Other studies have presented evidence which supports the theory that 
capsular material prevents phagocytosis by masking bound opsonins to 
make them ineffective. Peterson et al. (1978) showed that encapsulated 
and nonencapsulated strains of E.!.. aureus were virtually identical in 
their abilities to activate complement in noninnnune human serum, as 
determined by a complement consumption assay. The same group (Wilkinson 
et al., 1979b) later used electron microscopy and peroxidase-labelled 
anti-C3 IgG to show that C3 was localized on the cell wall of both 
encapsulated and nonencapsulated E.!.. aureus, implying that the capsule 
does not act as a barrier to either the early complement components 
or to IgG molecules. They also showed that in the presence of non-
innnune serum, C3 was found beneath the capsular polysaccharide and the 
organisms were not effectively opsonized. In the presence of type-
specific innnune serum, however, anti-capsular antibodies were found to 
be distributed throughout the capsule and the organisms were opsonized. 
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They suggested, then, that the mechanism of resistance to phagocytosis 
by the encapsulated strain was related to the physical masking of bound 
C3 molecules by the capsule, preventing the interaction of activated C3 
(C3b) with receptors in the PMN plasma membrane. They further suggested 
that when anti-capsular antibodies are present, phagocytosis is mediated 
via their Fe fragments which are located on the capsule surface. 
Perhaps a general mechanism for resistance of encapsulated organisms 
to phagocytosis cannot be constructed, at least within the current 
framework of knowledge. As stated in a recent review of the subject, 
Either or both of these mechanisms [the two presented above] 
may account for microbial resistance to phagocytosis, 
depending on the organism being studied, the nature of the 
opsonin (complement or antibody), and possibly, the type of 
phagocytic cell (Densen and Mandell, 1980, p. 825). 
A final possible role of capsular material in the pathogenesis of 
bacteria was proposed by Schwab (1975) who reported that the capsular 
material of~ pneumoniae was immunosuppressive in mice. Intramuscular 
injection of Klebsiella polysaccharide 3 to 30 days before an injection 
of bovine serum albumin resulted in depression of the normal antibody 
response to the albumin. He considered the response to be a type of 
immunological paralysis. 
Statement of the Research Problem 
It has been known for many years that capsular material exists on 
Pasteurella haemolytica. However, little is known about its involvement 
in pathogenicity of the organism. Before an assessment of the role of 
capsular material on a bacterium can be made, one must first demonstrate 
its presence ~nd then produce organisms without it. Comparisons then 
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can be made between bacteria which are encapsulated and those which are 
not. The objectives of this study were: to develop a rapid and 
reliable capsular staining technique and a capsular extraction procedure 
which would yield live cultures of decapsulated bacteria; to compare 
the resistance of encapsulated and decapsulated organisms to the agglu-
tinating and bactericidal effects of sera from inunune and noninunune 
cattle; to compare the resistance of encapsulated and decapsulated 
organisms to phagocytosis by and toxicity for bovine phagocytes; and 
to determine the general biochemical nature of the capsular extract and 
evaluate its inununologic and toxicologic relationship to P. haemolytica 
cytotoxin. 
CHAPTER II 
THE DEMONSTRATION OF AGE-DEPENDENT CAPSULAR 
MATERIAL ON PASTEURELLA HAEMOLYTICA 
Introduction 
Pasteurella haemolytica serotype 1 is the major cause of the severe 
fibrinous pneumonia that occurs in shipping fever of cattle (Rehmtulla 
and Thomson, 1981). As early as 1956, the presence of soluble capsular 
material on R..:_ haemolytica was demonstrated and its polysaccharide nature 
was established (Carter, 1956a). Capsular material or diffusable surface 
antigens have been used subsequently to determine the serotype of this 
organism (Biberstein et al., 1960; Carter, 1956; Frank and Wessman, 1978). 
Recently, material, presumably capsular, has been extracted from 
R..:_ haemolytica by several techniques (Evans and Wells, 1979; Gentry 
et al., 1982; Tadayan and Lauerman, 1981). Vaccination of mice, hamsters 
(Mukker, 1977; Tadayan and Lauerman, 1981), and sheep (Gilmour et al., 
1979; Wells et al., 1979) with these extracts has been shown to protect 
them against experimentally induced pasteurellosis. 
In its description of R..:_ haemolytica, Bergey's Manual states 
"capsular material not usually demonstrated by microscopical methods" 
(Smith, 1974). Capsules on R..:_ haemolytica from sheep have reportedly 
been demonstrated, and quantitative differences have been described 
between smooth and rough cell types (Biberstein et al., 1958). However, 
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we have been unable to find any publications which include photographs 
of encapsulated organisms. 
The purposes of the studies reported herein -were to demonstrate the 
capsule on.!'...:._ haemolytica serotype 1 and to examine the effect of 
culture age on capsular integrity. Studies with other serotypes of 
.!'...:._ haemolytica were not performed. 
Materials and Methods 
Culture Media 
Two solid types of media were used for culturing the organisms. 
The first was a modified brain heart infusion agar (Difeo Laboratories, 
Detroit, MI) which contained 5% bovine blood, 10% horse serum (M.A. 
Bioproducts, Walkersville, MD), and 1% yeast hydrolysate (ICN 
Pharmaceuticals, Cleveland, OH). In addition, a modification of 
Sawata's medium (Kume et al., 1978) with a brain heart infusion base 
was used. A corresponding Sawata's broth was also used. 
Microorganism 
The organism used throughout the study was.!'...:._ haemolytica serotype 
1 (Frank and Wessman, 1978), originally isolated from a feedlot calf. 
The organism was maintained in the lyophilized state. For each experi-
ment, a lyophilized culture was reconstituted with distilled water and 
streaked for isolation onto appropriate media. After 22 hr of incuba-
tion at 37° Cina candle jar, isolated colonies were suspended in 
0.01 M phosphate buffered saline (PBS) (pH 7.2), and the resulting 
suspension was used to inoculate fresh media. Cultures on solid media 
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were incubated for various times at 37° Cina candle jar. Broth 
cultures were incubated at 37° Cina shaking water bath. 
Fluorescent-Antibody Technique (FAT) 
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Antiserum to R...!_ haemolytica serotype 1 was made by injecting 
chickens intravenously with whole cells at four 1-week intervals as 
described previously (Gentry et al., 1982). Pooled antisera were then 
conjugated with fluorescein isothiocyanate (BBL Microbiology Systems, 
Cockysville, MD) (Corstvet and Sadler, 1964). At 2-hr intervals after 
inoculation (up to 22 h_r), thin smears of water-suspended organisms were 
made on glass coverslips and allowed to air dry. Smears were 
subsequently fixed in acetone for 10 min and stained with conjugated 
antiserum for 25 min at 37° C. A 1:5 dilution of antiserum was found 
to be optimal. The coverslips were then washed in 3 changes of PBS for 
a total of 20 min, mounted on glass microscope slides with a 90% PBS-
10% glycerol mounting medium (pH 7.2), and examined microscopically 
with an ultraviolet light source. 
Capsular Staining Techniques 
Maneval's method (Maneval, 1941). One drop of PBS-suspended 
organisms was mixed on a glass microscope slide with an equal drop of 
1% aqueous Congo red stain (Allied Chemical, New York, NY). The 
mixture was spread into a thin film smear and allowed to air dry. 
Without fixation, the smears were counterstained with Maneval's 
stain for 2 min, drained, and blotted dry. 
India ink method (Butt et al., 1936). Bacterial growth was 
suspended in sterile 6% glucose on a glass microscope slide. This 
suspension was then mixed with a drop of waterproof ink (Pelikan, 
Hannover, Germany). The mixture was spread into a thin film smear 
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and allowed to air dry. The smear was fixed for 1 min in absolute 
methanol, rinsed in water, counterstained with 1% aqueous crystal 
violet (Difeo Laboratories, Detroit, MI) for 1 min, and rinsed in water. 
Jasmin's method (Jasmin, 1945). Bacterial growth was suspended 
on a microscope slide in PBS containing 0.75% phenol and 10% horse 
serum. A thin film smear was made from the suspension and allowed 
to air dry. The smear was fixed by rapid immersion in absolute 
methanol followed by flaming. It was counterstained with 1% aqueous 
crystal violet for 1 min and rinsed in water. 
Other methods. The eosin-serum and Hiss methods were performed 
as described previously (Hiss, 1905; Howie and Kirkpatrick, 1934). 
Smears stained by each technique were examined under a lOOx 
oil immersion lens of a light microscope. 
Results 
Smears prepared by the FAT showed very bright fluorescent staining 
of the cell walls. Organisms from cultures incubated for less than 
12 hr were surrounded by wide capsules that stained less intensely than 
the cell walls (Figure 2.la). Capsules appeared to be widest around 
organisms from 2-hr cultures. After 12 hr of incubation, the capsular 
material had a mottled appearance and only partially encircled the 
cells (Figure 2.lb). In smears prepared from cultures 16 hr or older, 
capsular material usually could not be demonstrated (Figure 2.lc). 
Figure 2.1. Demonstration of Age-Dependent Capsular Material with 
a Fluorescent Antibody Stain. !'....=._ haemolytica 
stained with fluorescein isothiocyanate-conjugated 
antiserum (x 500). (a) Cells from a 6-hr culture 
with capsules. (b) Cells from a 12-hr culture. 
Capsules have a ·mottled appea~ance. (c) Cells 





If present, the capsular material was often found only at the poles 
of the cells. 
Capsular material also was demonstrated surrounding 6-hr cells 
stained by Maneval's, Jasmin's, and the India ink methods. Capsules 
were not demonstrated by the eosin-serum or Hiss techniques. The 
results of staining by the Maneval's method correlated with the FAT 
in that capsules were clearly and consistently demonstrated on cells 
from6-hr cultures (Figure 2.2a). The bacterial cells stained red, 
and the background stained blue. The capsules appeared as a wide 
clear zone. Capsules were larger with this method than with any of 
the other light microscopy capsule staining techniques. The majority 
of the cells in a 22-hr culture appeared to have very little of the 
extracellular material, which again was concentrated at the poles of 
the cells (Figure 2.2b). The age-dependent character of capsular 
association with cells was demonstrated to occur on both solid media 
and Sawata broth. 
In the Jasmin preparation, capsules appeared as narrow clear 
zones around the cells, but both cells and background stained purple, 
and there was not sufficient contrast to make the capsules obvious. 
Repeated efforts and modifications did not significantly improve the 
quality of the preparations. The India ink method stained the cells 
purple and the background black. The capsules again appeared as clear 
zones around the cells. However, the granularity and darkness of 
the background made it difficult at times to see unencapsulated 
organisms or to measure the size of the capsules around encapsulated 
ones. 
Figure 2.2. Demonstration of Age-Dependent Capsular Material with 
Maneval's Stain. R...:._ haemolytica stained by the 
Maneval method (x 1, 250). (a) Cells from a 6-hr 
culture. Capsules appear as wide clear zones. 
(b) Cells from a 22-hr culture. Minimal capsular 





Capsular material was demonstrated on young cultures of.!'....!_ 
haemolytica serotype 1 by the FAT and other capsular staining techniques. 
The dry film India ink and Jasmin methods demonstrated capsular material, 
but Maneval's stain was superior to either in that it correlated with 
the FAT results, and the capsules appeared larger and more distinct. 
The Maneval's method is simple and rapid, making it excellent for 
following the dissolution of capsular material during extraction pro-
cedures, as well as for screening cultures or even individual colonies 
for capsule production. 
Exopolysaccharide production by several organisms has been reported 
to be dependent on culture age, but those organisms differ in the growth 
stages in which production occurs. A mucoid strain of Pseudornonas 
aeruginosa was shown in batch culture to produce polysaccharide through-
out the exponential growth phase, and both growth and polysaccharide 
production ceased simultaneously (Mian et al., 1978). For other 
organisms, notably Bacillus licheniformis (Troy, 1979) and Pseudomonas 
sp. strain MCIB 11264 (Williams and Wimpenny, 1977), capsular poly-
saccharide production was not concoijll11.itant with exponential growth of 
the organisms but was initiated in late log-phase and occurred primarily 
after the cultures entered stationary-phase. For type III Pneumococcus 
(Bukantz et al., 1941) and an organism identified as Aerobacter 
aerogenes (Duguid and Wilkinson, 1953), most of the total polysaccharide 
production occurred after cessation of logarithmic growth when cell 
numbers were greatest; but the rate of production per cell was highest 
in the early logarithmic-phase and declined progressively thereafter. 
It was further reported with!:.... aerogenes that the average capsule 
diameter increased during and after the log-phase to a maximum at 48 hr 
(Duguid and Wilkinson, 1953). 
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Our results with R.!_ haemolytica serotype 1 indicate that maximum 
cell-associated capsular material is produced during the early logarith-
mic growth phase. Capsules appeared to be widest in organisms from 
cultures 2 to 6 hr old and diminished gradually as the culture aged, 
until little capsular material remained on cells from cultures over 
16 hr old. A similar age dependency of capsular association has been 
demonstrated ultrastructurally with Klebsiella pneumonia (Schmid et al., 
1981). In that study, the majority of cells harvested in the stationary 
growth phase (36 hr) exhibited shrunken capsules with coarse and short 
filaments or no capsule at all, whereas a capsule was demonstrated on 
almost all bacteria harvested in the logarithmic growth phase (5 to 
12 hr). In addition, the hyaluronate capsule of a type 5 strain of 
group!_ streptococcus was reported to be present on cells from early 
log-phase cultures but absent on cells from cultures in the later 
log-and stationary-phases (Whitnack et al., 1981). 
The cause of the age-dependent phenomenon as demonstrated in 
R.!_ haemolytica, !.!._ pneumonia, and group!_ streptococcus is unknown. 
We have, however, observed (Gentry, unpublished data) that the cell 
wall ultrastructure of R.!_ haemolytica differs topographically in 
organisms from 6-hr as compared to 22-hr cultures. Alterations in 
cell wall integrity may allow leakage of intracellular components 
into the surrounding capsular material, resulting in either alter-
ations in capsular· pH or enzymatic degradation of the capsule. Such 
degradation has been shown to occur in Bacillus licheniformis (Troy, 
1973). The polyglutamic acid produced by late log-phase cells of this 
organism is originally bound firmly to the cell surface as a capsule. 
After maximum production, however, there is a fairly rapid loss of 
this capsular material without cell lysis due to elaboration into the 
culture medium of an endo-type, poly (y-D-glutamyl) depolymerase. 
In conclusion, the amount of capsular material associated with 
P. haemolytica serotype 1 cells is maximal in young (less than 12-hr) 
cultures. This indicates that to obtain capsular material in the 
quantities needed for chemical analysis or immunization studies, 
young cultures should be used. 
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CHAPTER III 
EXTRACTION OF CAPSULAR MATERIAL 
FROM PASTEURELLA HAEMOLYTICA 
Introduction 
Pasteurella haemolytica has long been associated with shipping 
fever or pneumonic pasteurellosis of cattle. A soluble capsular 
substance was demonstrated when~ haemolytica was cultured overnight 
on fresh beef infusion agar plates (Carter, 1956a). Carter stated this 
substance was polysaccharide in nature and removed it from the organism 
by heating at 56° C for 30 min in water or normal saline solution. 
Several investigators have subsequently attempted to correlate the 
specificity of immunity afforded to mice by whole cell bacterins of 
this organism to their capsular and/or somatic antigens (Biberstein and 
Thompson, 1965; Knight et al., 1969). 
Attempts have been made to use capsular extracts of~ haemolytica 
to confer immunity. A potassium thiocyanate (KCSN) extract of P. 
haemolytica serotype 1 cross protected mice against an intraperitoneal 
challenge infection of Pasteurella multocida type A (Mukker, 1977). 
KCSN extracts have also been reported to protect conventionally reared 
rams (Mukker et al., 1983) and calves (Yates et al., 1983) from 
experimentally induced pneumonic pasteurellosis. Sodium salicylate 
capsular extracts froml:!. haemolytica have also been utilized. The 
administration of a sodium salicylate extract protected 
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specific-pathogen-free lambs from an aerosol challenge exposure with the 
homologous organism (Gilmour et al., 1979, 1983). Capsular extracts 
continue to be pursued as possible immunizing agents in lieu of whole 
cell bacterins that have proved disappointing (Biberstein and Thompson, 
1965; Wilkie and Norris, 1975; Tadayon and Lauerman, 1981). 
Culture of~ haemolytica produce capsular material early (4-6 hr) 
in their growth cycle, a fact demonstrated by the direct fluorescent 
antibody (FAT) technique using antiserum to whole organisms (Corstvet 
et al., 1982a). By this technique, the capsule was further shown to 
disappear gradually as the culture aged so that little capsular material 
remained on the cells after approximately 16-22 hr of incubation. The 
purpose of the present study was to demonstrate the removal of capsular 
material from cells in the early logarithmic growth phase and to compare 
several methods of extraction for their efficacy and their deleterious 
effect on the cells. 
Materials and Methods 
Organisms Used and Culturing Procedure 
The organism used was~ haemolytica serotype 1 (Frank and Wessman, 
1978). This isolate was obtained originally from a feedlot calf and 
was maintained as described previously (Newman et al., 1982). Briefly, 
the culture was maintained in the lyophilized state and was passed 
periodically in the lungs of 5-8-~o-old calves, with isolation and 
lyophilization between each passage. For each experiment, the 
lyophilized culture was streaked onto modified Sawata's medium (Kume 
et al., 1978) and was incubated for 17-24 hr at 37° Cina candle jar. 
Isolated colonies were then chosen and suspended in 0.01 M phosphate 
buffered saline (PBS) pH 7.2. This suspension was streaked on freshly 
prepared plates of modified Sawata's medium for confluent growth and 
was incubated for either 6 hr or 12 hr. 
Preparation and Analysis of 
Capsular Extracts 
The organisms were removed from the agar surface with a cotton 
swab and were suspended in water or PBS. The bacterial suspensions 
were incubated for 1 hr in a water bath at room temperature (RT, 
approx. 25° C), 37° C, 41° C, 45° C, or 56° C, followed by centrifuga-
tion at 17,000 x g for 15 min. The resulting extracts consisted of the 
supernatant fluids which were removed and filter sterilized through 
0.2 µm filters. 
Optical density (OD) measurements were taken on 1:9 dilutions of 
the original suspensions at 650 nm in a spectrophotometer (Spectronic 
20, Bausch and Lomb) immediately before and after the extraction 
procedure. Viable counts were also performed on the pre- and post-
extraction suspensions by the spot-plate method. 
Protein determinations on the extracts were made by the BioRad 
procedure which utilizes protein binding to Coomassie Brilliant Blue 
(Bradford, 1976). Carbohydrate measurements, when included, were 
performed by the anthrone method (Dische, 1961) which tests for total 
hexoses, and by the a-naphthol reaction (Dische, 1961) which measures 
hexoses, pentoses, and methyl pentoses. 
Antisera 
All antisera used in the FA procedure, agglutination studies, and 
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the agar-gel diffusion tests were made by intravenous injections of 
7-wk-old male Cornish cross chickens with 1 ml of whole cells, 
cells after extraction, or capsular extracts at weekly intervals for· 
4 weeks. At the time of the first inoculation, an additional 0.5 ml 
of the appropriate immunogen mixed with an equal volume of Freund's 
incomplete adjuvant was given subcutaneously. Serum was collected by 
exsanguination 11 days after the final injection. 
Fluorescent Antibody Technique 
Thin smears of bacterial suspensions were made on glass coverslips 
and were allowed to air dry. They were fixed for 10 min in acetone and 
stained for 25 min with a 1:4 dilution of fluorescein isothiocyanate 
conjugated chicken serum made to whole P. haemolytica cells (Corstvet 
and Sadler, 1964). The coverslips were then washed in 3 changes of 
PBS for a total of 20 min, mounted on glass microscope slides with a 
PBS/glycerol mounting medium (pH 7.2), and examined microscopically 
with an ultraviolet light source. 
Serotests 
Agglutination studies were performed on the pelleted cells from 
pre- and post-extraction suspensions of 6-hr and 22-hr cultures. The 
cells were suspended in a drop of antiserum and observed for 1 min for 
macroscopic agglutination. 
The agar gel diffusion technique was used (0.9% Noble agar with 
8.5% NaCl) (Heddlesten et al., 1972). Capsular extracts were placed 
in the center well and antisera from chickens that had been given 
whole cells, cells after extraction, or capsular extracts were placed 
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in the outer wells. Plates were incubated at 37° C and were examined 
daily for 4 days. 
Results 
A PBS suspension of a 6-hr culture of R..=._ haemolytica stained 
by the FAT showed a wide zone of capsular material around the 
majority of cells (Figure 3.la). Capsular material was no longer 
demonstrable on cells from the same suspension after incubation at 
41° C for 1 hr (Figure 3.lb). 
When PBS was used as the suspending medium, an extraction tempera-
ture of 41° C was necessary to remove the capsular material from the 
cells, as seen by examination in the fluorescent microscope. There 
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was little decrease in OD and cell viability in PBS suspensions at the 
extraction temperatures of RT, 37° C, or 41° C. It was not until the 
temperature of incubation was raised to 45° C that a substantial 
decrease in OD and viability of the suspension was observed (Table 3.1). 
Capsules were also extracted from cells suspended in water. In 
this case, a lower incubation temperature (37° C) was sufficient to 
remove the capsular material (Table 3.1). However this treatment 
resulted in approximately a 2 log unit decrease in the viable count of 
the suspension. At higher temperatu~es, OD and viability decreased 
further. At room temperature, the viability decrease was low (O.l 
log U), but the capsular material was not removed from the cells 
according to the FAT. 
Protein determinations were made on extracts from various 
experiments (Table 3.2). Certain generalizations may be made from 
these data, even though numbers of cells in the suspensions varied 
Figure 3.1. Demonstration with Maneval's Stain of Decapsulation of 
Organisms by a Capsular Extraction Technique. Cells 
from 6-hr cultures of~ haemolytica stained by the 
FA technique. (a) Pre-·extraction cells. (b) Cells 
from the same suspension after incubation for 1 hr 
at 41° C in PBS x 500 oil immersion. 
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In degrees C (RT= room temperature) of 1 hr incubation. 
Ion 650 of a 1:9 dilution of the cell suspension. 









most of capsular material 
most of capsular material 
capsules removed 
capsules removed 
§As determined by staining with fluorescein isothiocyanate-labeled antiserum. 
t Average results from 5 trials. 
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BIORAD PROTEIN DETERMINATIONS ON CAPSULAR EXTRACTS 
Average Protein 
* 
Number of Concentration 
Extraction Temperature Trials (mg/ml) 
Water extracts 
RT. 4 0.34 
37° 7 0.53 
41° 4 0.79 
45° 2 0.52 
56° 4 0.51 
PBS extracts 
RT 1 0.11 
37° 2 0.15 
41° 4 0.10 
45° 1 0.20 
56° 1 0.22 
* (RT room temperature). In degrees C 
somewhat from experiment to experiment and thus the extract protein 
concentrations cannot be compared absolutely. The protein content 
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was higher for the extracts made in water than for those made in PBS. 
Also, in all water extraction trials in which several extracts were 
made from the same cell suspension at several temperatures, the protein 
concentration peaked at 41° C and the 45° C and 56° C extracts had a 
lower concentration. 
Carbohydrate determinations were performed in one experiment, using 
a common cell suspension, and thus may be directly compared with one 
another (Table 3.3). The amount of carbohydrate in the various extracts 
tested was constant (62-78 µg/ml) regardless of the suspending medium 
and the extraction temperature used. 
Untreated 6-hr cells with intact capsules were more difficult to 
agglutinate with all 6 antisera tested than were untreated 22-hr cells 
(Table 3.4). When 22-hr cells were treated by the extraction procedure, 
there was little change in agglutinability. However, when the capsules 
were removed from 6~hr cells, agglutination occurred more readily, 
and serum titers approximated those of 22-hr cells. 
An agar gel diffusion plate with a 6-hr extract made in water 
at 37° C placed in the center well and sera from chickens inoculated 
with various cell suspensions or extracts as indicated in the outer 
welis,revealed that there was a major band missing from the reaction 
with antiserum made to 6-hr post-extraction cells (Figure 3.2). 
There were at least three separate precipitin bands in the reaction 
between the 6-hr extract and antiserum made to 6-hr or 22-hr whole 
cells (wells 1, 3, and 4; Figure 3.2). All three bands were also 
present when the antiserum used was made to 6-hr capsular extract 
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TABLE 3.3 
CARBOHYDRATE DETE~INATIONS ON SELECTED CAPSULAR EXTRACTS 



























AGGLUTINATION TITERS OF CHICKEN ANTISERA FOR ENCAPSULATED AND DECAPSULATED ORGANISMS 
6-hr 22-hr 
* 
22-hr 6-hr extracted extracted 
Antiserum Used whole cells whole cells cells cells 
6-hr whole cells 1:16 1: 4 1:32 1:32 
6-hr extracted cells 1:16 1:2 1: 16 1: 8 
Extract from 6-hr cells 1:4 1:2 1:4 1:4 
22-hr whole cells 1:32 1:2 1:16 1:16 
22-hr extracted cells 1: 16 1 : 1 1:16 1:16 
Extract from 22-hr cells 1:4 NA 1:4 1:4 
* Antisera prepared against the immunogens listed by 4 weekly intravenous 1 ml injections of 7-wk-old 
male Cornish cross chickens. Cell suspensions made in H20 were extracted by incubation for 1 hr at 37° C. 
NA= not agglutinable. 
Figure 3.2. Photograph and Schematic Representation of Agar-Gel 
Diffusion Plate Used to Confirm Loss of an Antigenic 
Component by Decapsulated Organisms. Photograph (2a) 
and schematic representation (2b) of agar-gel 
diffusion plate, using capsular extract from 6-hr 
cells in the center well and antisera in the outer 
wells from chickens inoculated with the following 
antigens: · (1) 6-hr whole cells; (2) non-immunized 
control serum; (3) 22-hr whole cells; (4) 6-hr cells; 
(5) 6-hr extract; (6) 6-hr extracted cells. A, B, and 





(well 5), although band B was noticeably less intense. When the 
antiserum used was made to 6-hr extracted cells (well 6), however, 
not only was band Bless dense, but band C was barely discernible. 
Normal chicken serum (well 2) did not react with the antigen. 
Discussion 
Cells from early logarithmic-phase cultures of~ haemolytica 
were encapsulated as demonstrated by the FAT. Capsular material 
has been shown to disappear gradually as the culture ages until it is 
no longer demonstrable in 16-22-hr cultures (Corstvet et al., 1982a). 
Concurrent with loss of capsular material, the cells are agglutinated 
more easily and also become osomotically fragile, as indicated by a 
considerable decline over a 1-hr period in OD and viable count of 
water suspensions of 22-hr cells (Gentry, unpublished data). 
Results of the present studies show that capsular material may 
be removed from young cultures of..!'....:_ haemolytica by a 1-hr incubation 
of PBS suspended cells at 41° C. With this treatment, there was 
little loss of cell viability, whether or not the capsular material 
was removed, until the extraction temperature reached 45° C. At 
this temperature, the lethal effect of heat itself must be considered. 
By contrast, the capsular material was removed from 6-hr cells 
suspended in water at an extraction temperature of 37° C. Concurrent 
with capsular removal was at least 1.5 log U decrease in the viable 
count of the suspensions, even at 37° C and 41° C. This loss of 
viability was not seen when the water-suspended cells were incubated 
at RT, a temperature at which the capsular material remained on the 
cells. It was concluded, therefore, that removal of capsular material 
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caused 6-hr cells to become osmotically fragile, comparable to those 
in a 22-hr culture, and the isotonicity of PBS provided a more 
protective environment, preventing cell lysis. 
Freshly isolated encapsulated strains of P. haemolytica have been 
reported to be inagglutinable, whereas daily subculture for three 
weeks rendered the same organisms agglutinable (Tweed and Eddington, 
1930). In the present studies, young (6-hr) encapsulated cells were 
more difficult to agglutinate than were those from the same culture 
after an additional 16 hr of incubation. After extraction, however, 
the 6-hr organisms agglutinated more easily, an additional indication 
that the capsular material had been removed. 
Agar gel diffusion tests revealed that there were at least three 
antigens present in a 6-hr capsular extract that are also present on 
6-hr whole cells. The presence of identical bands when antiserum to 
22-hr whole cells was used may be explained by the fact that 22-hr 
cell suspensions used to stimulate antiserum production in chickens 
contained a small percentage of encapsulated cells, as seen by FAT. 
It is also possible that the 22-hr cells multiply to a limited extent 
in the chicken, thus presenting young encapsulated organisms to the 
immune system. Further, a small amount of capsular antigen from the 
agar plates may have been picked up by the swab and incorporated into 
the antigen preparation as the cell suspensions were made. Because 
band C was present in the reaction between 6-hr extract and antiserum 
to 6-hr extract or to whole cells but not when antiserum to 6-hr 
extracted cells was used, this band was assumed to be a capsular anti-
gen that was removed during the extraction procedure. The faint band 
that did appear could reflect the failure to wash the extracted cells 
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before injecting them into the chickens, allowing a small amount of 
capsular antigen to be retained in the preparation. 
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The capsular extracts were shown to contain protein and carbo-
hydrates, although it was not clearly understood how much of these 
components were leached from the cell interior and how much were truly 
of capsular origin. The amount of carbohydrate present was relatively 
constant (62-78 µg/ml), regardless of the extraction method used. The 
protein content, however, varied greatly (0.1-0.79 mg/ml). The water 
extracts contained 2.3 to 7.9 times more protein that did PBS extracts 
prepared at corresponding temperatures. These differences were thought 
to be due to increased cell lysis or leaching of intracellular proteins 
when the cells were incubated in a hypotonic environment. Capsular 
extracts prepared in water at 45° C and 56° C contained less protein than 
did extracts prepared from the same cell suspension at either 37° C or 
41° C, possibly due to breakdown at the higher temperatures of protein 
into polypeptides too small (<3000 mol wt) to be recognized by the 
protein binding assay. In contrast, the protein content of PBS 
extracts continued to increase with increasing extraction temperature. 
In this case, the heat related breakdown of proteins was thought to be 
overshadowed by an increase in cell lysis and leakage as shown by the 
greater decreases in OD and viable count of PBS suspensions incubated 
at 45° C and 56° C than in those incubated at 41° Corless. 
The extraction procedure of choice for removing capsular material 
with minimal concurrent cell destruction was determined to be that of 
incubating a PBS suspension of the organism at 41° C for 1 hr. The 
use of this extraction procedure permits the preparation of comparable 
cell suspensions with and w~thout their capsules, such that the 
pathogenicity and immunogenicity of the cultures may be investigated. 




INTERACTION OF ENCAPSULATED AND DECAPSULATED 
PASTEURELLA HAEMOLYTICA WITH BOVINE SERA 
Introduction 
Pasteurella haemolytica, the gram negative pleomorphic bacillus 
which is associated with the characteristic lesions of shipping fever 
in cattle, has been shown to be encapsulated, at least during the 
early logarithmic-phase of growth on artificial media (Corstvet et al., 
1982a). Capsules also have been observed surrounding organisms in 
pleural fluid taken at necropsy from calves with experimental pneumonic 
pasteurellosis (Gentry, unpublished data). The role of the capsular 
material in the pathogenesis of shipping fever has not, to date, been 
investigated. 
Bacterial capsules have long been thought to be virulence factors 
(Wilkinson, 1958). The presence of a well defined capsule has been 
shown to enhance resistance to the bactericidal effects of host serum 
components on many gram negative bacteria, including Klebsiella 
aerogenes (Williams et al., 1983), Salmonella typhi (Muschel et al., 
1958), Haemophilus influenzae (Branefors and Dahlberg, 1980), and 
Escherichia coli (Taylor, 1975). It has been theorized that 
capsular material may impede binding of cell surface-specific antibody 
and subsequent insertion of the membrane attack complex of the complement 
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cascade (C5-C9) responsible for the lethal lesion on the cytoplasmic 
membrane of the organisms (Glynn and Howard, 1970). However, specific 
anti-capsular antibodies have been shown to activate complement leading 
to a bactericidal reaction (Bjornson and Michael, 1970; Goldschneider 
et al., 1969). It has also been shown that anti-capsular antibodies 
might be helpful in protecting hosts from diseases due to encapsulated 
organisms including Pasteurella multocida (Hofing et al., 1979) and 
Pasteurella haemolytica (Gilmour et al., 1983; Mukkur et al., 1983). 
The purpose of these studies was to determine if development of a 
capsule by R.:_ haemolytica, serotype 1 enhances resistance of the 
organisms to the bactericidal activity of bovine serum. The contribu-
tion of complement and antibodies in sera obtained from animals exposed 
naturally or experimentally to the whole organism or an extract of its 
capsular material were examined and discussed. 
Materials and Methods 
Microorganism 
The organism used throughout the study was Pasteurella haemolytica, 
biotype A, serotype 1 originally isolated from a feedlot calf (Corstvet 
et al., 1973). The organisms were maintained in the lyophilized state. 
For each experiment, a lyophilized culture was reconstituted with 
distilled water and streaked for isolation onto a modified Sawata's 
medium (Kume et al., 1978). After 18-22 hr of incubation at 37° C in 
a 5% co 2 atmosphere, isolated colonies were suspended in 0.01 M 
phosphate buffered saline (PBS) (pH 7.2), and the resulting suspension 
was streaked for confluent growth onto fresh plates of modified Sawata's 
medium. These plates were incubated as described above. When growth 
reached the early logarithmic-phase, the cells were harvested with a 
cotton swab and suspended in PBS. Such suspensions typically 
contained encapsulated organisms (EO) as determined by Maneval's 
staining technique (Corstvet et al., 1982a). 
Decapsulated organisms (DO) were prepared as previously described 
(Gentry et al., 1982). Briefly, PBS suspensions of encapsulated 
organisms were incubated for 1 hr on a shaking platform in a 41° C 
water bath. The organisms were then collected by centrifugation at 
10,000 x g for 20 min and resuspended_in fresh PBS. The extraction 
procedure reliably removed most of the capsular material from the 
organisms as shown by a Maneval stain of the resulting suspension. 
Approximate concentrations of organisms in the suspensions were deter-
mined photometrically. Actual numbers of colony forming units (CFU)/ml 
were determined by a spot plate method following serial dilution. 
Sera 
Eight bovine sera coded as AL, AC, unexposed, natural exposure A, 
natural exposure B, bacterin A, bacterin B, and FBS were utilized. 
The serum referred to as anti-live (AL) came from an animal repeatedly 
innnunized with live P. haemolytica by both aerosol and subcutaneous 
injection routes. The serum referred to as anti-capsular (AC) came 
from an animal which was injected subcutaneously 3 times at 1 wk 
intervals with 18 ml of a saline capsular extract from R...!_ haemolytica 
mixed with an equal volume of Freund's incomplete adjuvant. The sera 
designated unexposed, and natural exposure A and B came from calves 
which were not vaccinated, but were part of a herd in which many of 
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the animals had high antibody titers to R..!_ haemolytica, apparently as a 
result of natural exposure to the organism. The sera designated bacterin 
C and D came from animals which received two 5 ml intradermal injections 
1 wk apart of a formalin-killed culture of R..!_ haemolytica (with an 
optical density eq~al to that of lxl09 CFU/ml) adsorbed to aluminum 
hydroxide in gel adjuvant. Control sera consisted either of germ-free 
calf serum (kindly provided by Dr. Merwin Frey, Lincoln, NE) or 
connnercially available fetal bovine serum (FBS) (BioLabs, Inc., 
Northbrook, IL). Heat-inactivated (HI) sera were prepared by incubating 
serum samples at 56° C for 30 min. 
Measurement of serum antibody titers to somatic antigens of P. 
haemolytica was accomplished by a quantitative immunoassay (FIAX) as 
previously described (Confer et al., 1983). Results were expressed as 
titer values as determined by comparison to known standards. In 
addition, FIAX measurements of the sera were determined against a 
saline capsular extract from the organism prepared by a method reported 
previously (Gentry et al., 1982). Results were expressed as fluorescent 
signal units (FSU). 
Samples of AL and AC sera were preadsorbed by incubation with DO 
for 30 min at 4° C. The organisms were then removed by centrifugation 
and the sera filter-sterilized. 
Exogenous Complement Sources 
In certain experiments lyophilized samples of guinea pig complement 
(Flow Laboratories, McLean, VA) were reconstituted according to manu-
facturer's package instructions and added to HI serum samples as a 
source of exogenous complement. Various dilutions of guinea pig 
complement were used, such that 2.2 to 22.2 hemolytic units (as deter-
mined by the method of the National Veterinary Services Laboratories, 
1979) were added to the bactericidal reaction mixtures. In other 
experiments, serum from a young dairy calf with a FIAX titer of 0.0 to 
!'..!._ haemolytica was used as a complement source. Blood was collected 
in a vacutainer tube and allowed to clot at 4° C for 1 hr. The serum 
was collected and preadsorbed with DO as above, and then immediately 
frozen at -70° C in small aliquots. A complement titration of the 
serum was performed by the method of Mueller et al. (1983) and 5.3 
hemolytic complement units were added to the bactericidal reaction 
mixtures. HI complement sources (56° C, 30 min), which were devoid of 
hemolytic complement activity, were used as controls in these 
experiments. 
Direct Bacterial Agglutination Test 
The antigens used were prepared by a modification of the method 
of Friend et al. (1977), EO and DO were incubated at 4° C for 30 min 
in 0.4% formalized PBS, washed twice in PBS, and resuspended in 0.4% 
formalized PBS to an optical density of 1.0 at 525 nm. Two-fold serial 
dilutions of antisera were added to equal volumes of appropriate 
antigen in tubes (13x 75 mm). All tubes were incubated at 37° C for 
48 hr and examined for macroscopic agglutination. 
Bactericidal Test 
The reaction mixture consisted of 0.4 ml of a PBS suspension of 
EO or DO containing approximately lxl08 colony forming units (CFU)/ml, 
0.1 ml of RPMI 1640 tissue culture medium (GIBCO Laboratories, Grand 
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Island, NY), and 0.1 ml of the serum to be tested. The mixture was 
blended vigorously on a vortex mixer _for 5 sec and O .1 ml of the mixture 
was immediately pipetted into 9.9 ml of PBS for a zero time sample. 
Additional 0.1 ml aliquots of the mixture were pipetted into 3 or 4 
sterile plastic tubes that were then incubated on a shaking platform 
in a 37° C water bath. After various time intervals (15, 30, 45, or 
60 min), a single tube was removed from the water bath and diluted with 
9.9 ml of cold PBS to reduce further antibacterial action of the serum. 
All tubes were held on ice until viable counts could be performed by 
serial dilution and a spot plating technique. In certain experiments, 
the 0.1 ml of media was replaced by an equal volume of exogenous 
complement source. 
The percentage change in viability at a given sampling time (n) 
was calculated by the following formula: 
·% Change CFU/ml at time n - CFU/ml at time O] x 100 
CFU/ml at time O 
Thus a negative% change indicates killing of the organisms and a 
positive% change indicates growth of the organisms. 
Statistical Analysis 
Comparisons of% change in CFU/ml and FIAX reactions of sera to 
either formalin-killed organisms or capsular extract were made by 
linear regression analysis (Bailey, 1981) . 
Results 
For the eight sera used in these studies, FIAX titers to formalin-
killed organisms ranged from Oto 652. FIAX responses to the saline 
capsular extract ranged from 8 to 146 FSU (Table 4.1). Agglutination 
titers against both EO and DO were determined for 5 of the sera (Table 
4.1). If the sera were arranged according to the descending order of 
their FIAX titers against formalin-killed organisms, they would also be 
arranged in descending order of their agglutination titers against DO. 
They would not be in order of their agglutination titers against EO, 
however, as EO was agglutinated at an 8-fold higher dilution by AC 
serum than by any of the other sera t~sted. 
Curves were constructed for the% change in CFU/ml for EO and DO 
upon incubation with individual serum samples. Examples of typical 
types of curves determined for% change in CFU/ml of EO with four of 
the sera are shown in Figure 4.1. For 2 of the 4 sera, the number of 
CFU/ml decreased between O and 30 min, followed by apparent regrowth 
77 
of surviving organisms between 30 and 60 min. Therefore, the% change 
in CFU/ml at 30 min was used to compare the effects of the sera tested 
on EO and DO. The effects of different sera on bacterial viability 
varied from a 98.3% reduction to a 138% increase in CFU/ml after 30 min 
of exposure (Figure 4.2). EO were resistant to killing by all but three 
of the sera: AL, AC, and Natural Exposure A. DO, however, had a 
decrease in CFU/ml to each of the sera tested except for FBS. 
Regression analyses were performed to determine the correlation 
between the% change in CFU/ml after 30 min exposure and the FIAX 
reactions of the sera for both formalin-killed organisms (Figure 4.3) 
and capsular extract (Figure 4.4). DO were much more susceptible to 
serum killing,such that the Y intercepts for the DO regression lines 
were 9.9 and -2.8 respectively, as compared to 92.9 and 152.8 for EO. 
Also, the slopes of the regression lines are similar (-70.5 vs. -60.2, 
TABLE 4.1 
AGGLUTINATION AND FIAX TITERS OF BOVINE ANTISERA 
Agglutination Agglutination FIAX Titer 
Titer Titer - ~gainst 
Against Against Formalized 
Serum EO DO Organisms 
Anti live organisms (AL) 32 256 652 
Anti-capsular (AC) 512 32 521 
Fetal Bovine Serum (FBS) 0 
Unexposed Calf 2 2 0 
Natural Exposure A 2 8 228 
Natural Exposure B 8 4 170 
Bacterin C 66 















Figure 4.1. Curves of% Change in CFU/ml of Cultures of Encapsulated 
Organisms Exposed to Bovine Sera. Curves of% change 
in viability of suspensions of encapsulated organisms 
incubated with 16.7% bovine sera for 1 hr at 37° C. 
Lines represent% change in CFU/ml as determined by a 
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Figure 4.2. % Change in CFU/ml of Encapsulated and Decapsulated 
Organisms Exposed to Bovine Sera. Comparison of 
bactericidal action of bovine sera on encapsulated 
and decapsulated organisms. Bars represent% change 
in CFU/ml of bacterial suspensions after incubation 
for 30 min at 37° Cina medium containing 16.7% 
bovine serum. 
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Figure 4.3. Correlation Between% Change in CFU/ml and Log FIAX 
Titer to Formalin-Killed Organisms. Regression curve 
for% change in CFU/ml of suspensions of encapsulated 
or decapsulated organisms after 30 min exposure at 
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Figure 4.4. Correlation Between% Change in CFU/ml and FIAX 
Reaction (FSU) to Capsular Extract. Regression curve 
for% change in CFU/ml of suspensions of encapsulated 
or decapsulated organisms after 30 min exposure at 
37° C to bovine sera vs FIAX reactions (FSU) to 
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and -1.43 vs. -0.84) and the lines do not intersect. The correlation 
coefficient (r) between the% change in CFU/ml of EO and the FIAX 
reaction of the sera to capsular extract (r = -0.7026, p = 0.05) was 
higher than that between% change in CFU/ml and the FIAX titer to 
formalin-killed organisms (r = -0.5920, p > 0.1). The opposite was 
found with DO, such that the correlation coefficient was higher between 
% change in CFU/ml and FIAX titer to organisms (r = -0.9069, p < 0.01) 
than between% change in CFU/ml and FSU to capsular extract (r = -0.7369, 
p 0.05). 
Heat-inactivation of the sera generally reduced, but did not pre-
vent, their bactericidal activity. Figure 4.5 shows the effect of heating 
AL serum on its bactericidal activity against EO. Both the rate of 
killing and the total% decrease in CFU/ml at 30 min were reduced. 
However HI serum was still bactericidal. Addition of fresh calf serum 
to the reaction mixture partially restored bactericidal activity. 
HI serum from the same calf did not restore bactericidal activity. 
Similar results were found with AL serum and DO (graph not shown). 
Addition of fresh calf serum did not restore the original bactericidal 
activity to any of 5 HI serum samples tested. Results were essentially 
the same using guinea pig complement in place of the fresh bovine serum. 
Heat-inactivation of AC serum produced a different effect than 
that seen for AL serum, but only when EO were utilized in the assay 
(Figure 4.6). Non heat-inactivated serum reduced the% CFU/ml by 89% 
after 30 min of exposure. Heat-inactivation completely destroyed the 
bactericidal capacity of AG serum, such that rapid growth of the 
organisms occurred. Addition of fresh calf serum or guinea pig 
complement partially restored the killing capability. However, addition 
Figure 4.5. Effect of Heat-Inactivation of Anti-Live Serum on 
Encapsulated Organisms. Effect of heat-inactivation 
and addition of exogenous complement on the bacteri-
cidal action of anti-live serum for encapsulated 
organisms. Heat-inactivated serum was incubatea at 
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Figure 4.6. Effect of Heat-Inactiva'tion of Anti-Capsular Serum 
on Encapsulated Organisms. Effect of heat-
inactivation and addition of exogenous complement 
on the bactericidal action of anti-capsular serum 
for encapsulated organisms. Heat-inactivated serum 
was incubated at 56° C for 30 min, 
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of HI calf serum or guinea pig complement also promoted killing of the 
organisms to the same extent. The bactericidal capability of serum 
from natural exposure A calf was also completely destroyed by heat-
inactivation (data not shown). Addition of an exogenous complement 
source was not performed with that serum. 
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AL and AC sera, preadsorbed with DO in an attempt to remove 
antibodies to somatic but not capsular antigens, were compared to native 
sera in the direct bacterial agglutination, FIAX, and bactericidal tests 
with both EO and DO (Table 4.2). A substantial reduction of the direct 
bacterial agglutination titer occurred upon adsorption of both sera 
with DO. The titer of AL serum was reduced 4-fold for EO and 8-fold 
for DO, and the titer of AC serum was reduced 128-fold for EO and 
64-fold for DO. Except for the FIAX titer of AL serum to formalin-killed 
organisms, the FIAX reactions of the two sera were reduced less than 
2-fold. The FIAX reaction of AL serum to capsular extract was reduced 
by 13%. The FIAX reactions of AC serum to both formalin-killed 
organisms and capsular extract had reductions of 53% and 23%, 
respectively. 
Preadsorption of AL serum caused a reduction of its bactericidal 
capacity for EO similar to the effect of heat-inactivation of the 
serum (Figure 4.7). Preadsorption effected an even greater reduction 
of the serum's bactericidal capacity for DO. Preadsorption of AC serum 
also produced a change very similar to the effect of heat-inactivation 
of the serum (Figure 4.8). Adsorption of that serum with DO essentially 
removed its bactericidal capacity for EO and substantially reduced, but 
did not destroy, its killing capacity for DO. 
Figure 4.7. Effect of Preadsorption of Anti-Live Serum on 
Encapsulated and Decapsulated Organisms. Effect of 
preadsorption on the bactericidal action of anti-
live serum for encapsulated and decapsulated organisms. 
Serum was preincubated for 30 min at 4° C with 
decapsulated organisms. 
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Figure 4.8. Effect of Preadsorption and Anti-Capsular Serum on 
Encapsuiated and Decapsulated Organisms. Effect of 
preadsorption on the bactericidal action of anti-
capsular serum for encapsulated and decapsulated 
organisms. Serum was preincubated for 30 min at 
4° C with decapsulated organisms. 
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EFFECT OF PREADSORPTION ON AGGLUTINATION AND FIAX TITERS 
OF ANTI-LIVE AND ANTI-CAPSULAR SERUM 
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FIAX Reaction 
Agg. Agg. FIAX Titer (FSU) Against 
Titer Titer Formalized Capsular 
Serum for EO for DO Organisms Extract 
Anti-live (AL) 32 256 652 145.5 
AL preadsorbed with DO 8 32 652 126.5 
Anti-cap (AC) 512 128 521 69.0 
AC preadsorbed with DO 4 4 247 53.0 
Discussion 
The two main sera utilized in the study, AL and AC, were prepared 
so as to have different properties. AL serum was prepared by hyper-
immunizing a calf with metabolically active, encapsulated organisms. 
It was expected that the serum from the animal would thus contain 
antibodies to both somatic and capsular antigens from the organisms. 
AC serum was prepared by injecting a calf with a saline extract of 
f.=_ haemolytica capsular material with the aim of producing a serum 
containing anti-capsular, but not anti-somatic antibodies. In reality, 
both sera possessed high FIAX titers to formalin-killed organisms. 
The whole organism antigen used in the FIAX test was prepared from a 
stationary-phase c.ulture which showed very little capsular material 
upon staining (Corstvet et al., 1982a). It has also been our observation 
that capsular integrity is not maintained on formalin-killed organisms. 
The high titer demonstrated by AC serum for such aa antigen indicates 
that the serum indeed contains antibodies for 1'..!. haemolytica somatic 
antigens. Presumably, then; the capsular extract used to immunize the 
AC calf contained a significant quantity of somatic antigens. 
AL serum reacted twice as strongly against capsular extract as did 
AC serum in a FIAX test. This being the case, one would expect AL 
serum also to have a higher agglutination titer for EO than would AC 
serum. To the contrary, the agglutination titer of AL serum for EO 
was 16-fold lower than that demonstrated by AC serum, whereas its 
agglutination titer for DO was 8-fold higher than the AC serum titer. 
Because the capsular extract used as an antigen in the FIAX test was 
simply a concentrate of that used for the injection of the AC calf, it 
is reasonable to assume that at least a portion of the FIAX response 
shown by AL serum for capsular extract is specific for its contami-
nating somatic antigens. AL serum agglutinated DO at an 8-fold higher 
titer than it did EO, indicating that it possess more antibodies to 
somatic than to capsular antigens. In contrast, AC serum agglutinated 
EO at a 16-fold higher titer than DO, indicating that it possesses more 
antibodies to capsular than to somatic antigens. 
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DO were found to be more sensitive than EO to the bactericidal 
effect of each serum tested except for AL, which was slightly more 
lethal for EO than DO. EO were killed only by the three ser.a with the 
highest antibody levels, whereas DO were killed by all sera except FBS. 
These results imply that killing of EO was due only to antibody-mediated 
classical complement activation, whereas killing of DO could also be 
accomplished by non-antibody-mediated activation of complement. Such 
non-antibody-mediated complement activation has been shown to contribute 
to the killing of rough gram negative bacteria (Taylor, 1983). 
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Further experiments utilizing specific blockers of the alternate 
and/or classical complement pathways, would be helpful in determining 
differences in complement activation by encapsulated versus decapsulated 
organisms. In previous studies, a il.onencapsulated, but not an encapsu-
lated strain of Haemophilus influenzae was also found to be sensitive to 
a bactericidal, non-antibody factor present in preimmune rabbit serum 
(Branefors and Dahlberg, 1980). Perhaps in the present studies, 
decapsulation of the organisms rendered them sensitive to a similar 
non-antibody, bactericidal factor. 
The resistance of EO to the majority of sera tested appears to 
contradict the recent work of MacDonald et al. (1983) in which organisms 
in the logarithmic growth phase were found to be uniformly sensitive to 
the bactericidal activity of normal adult bovine blood with an indirect 
bacterial agglutination titer of 128. However, their reaction mixture 
contained 50% serum compared to 16.7% serum used in the present studies, 
and they found that dilution of their serum to 25% precluded the 
bactericidal reaction. 
Serum from neither of the animals receiving bacterins was bacteri-
cidal for EO. Their FIAX reactions to capsular extract were also the 
lowest among the sera from animals exposed to the organisms, as might 
be expected from vaccination with a killed product. A comparison of 
the correlation coefficients between the bactericidal capacities 
(% change in CFU/ml) and the FIAX reactions of the sera showed that the 
FIAX reaction against capsular extract was a better predictor of the 
serum bactericidal action against EO, while the FIAX titer to formalin-
killed organisms better predicted serum action against DO. 
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In all cases heat-inactivation of the sera that were bactericidal 
for DO reduced both the rate of killing and the percentage of organisms 
killed after 60 min of exposure. Heat treatment did not prevent their 
bactericidal action against DO. Heat-inactivation of 2 of the 3 sera 
found to be bactericidal for EO, however, rendered them completely 
nonbactericidal. Addition to HI antisera of complement-rich fresh calf 
serum that did not contain antibodies specific for~ haemolytica, in 
all cases restored a portion of the bactericidal action of the sera. 
Similar partial restoration of bactericidal activity of HI serum by 
exogenous complement sources has be~n reported for H. influenzae (Musher 
et al., 1983) and~ h~emolytica (MacDonald at al., 1983). In the 
studies described herein, addition of a HI complement source, intended 
as a control, also enhanced the bactericidal effect of the majority of 
the sera tested. The reason for· this phenomenon is not clear. Heat-
inactivation of serum destroys only the early complement components and 
leaves the membrane attack complex intact. A number of workers have 
presented data suggesting that the membrane attack complex may be formed 
after activation by mechanisms distinct from either the classical or 
alternate pathways (Taylor, 1983). Perhaps the protease shown to be 
associated with the cytotoxin produced by~ haemolytica (Otulakowski, 
1983) was able to enzymatically cleave the CS complement component, 
leading to its activation in the absence of functional C3. As the 
original serum concentration used in these studies (16.7%) was lower 
than the 20% recommended by Taylor (1983) to ensure that killing is not 
limited by availability of essential complement components, the addition 
of extra serum (to a total serum concentration of 33.3% may simply have 
provided enough of the latter components to allow killing after enzy-
matic complement activation. 
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The results of the agglutination and FIAX tests for AL and AC sera 
which had been preadsorbed with DO indicate that adsorption was 
incomplete. The adsorbed sera were still capable of agglutinating both 
EO and DO, and also retained significant FIAX titers to formalin-killed 
organisms. In fact, the FIAX titer of AL serum to organisms was not 
reduced at all. It may be that the titer of AL serum was so high that 
even after reduction by adsorption, the antibody level was sufficient 
to exceed the upper limit of sensitivity of the FIAX system. The 
reduction in titer measured by the agglutination test, which is much 
less sensitive than the FIAX test, indicates that adsorption did reduce 
the antibody level of AL as well as that of AC serum. 
In general, the effect of preadsorption of both AL and AC sera 
on their bactericidal capacity was the same as that of heat-inactivation. 
As mentioned above, reduction in antibody titer would not explain such 
an effect, because the titers were still quite high after adsorption. 
Perhaps adsorption removed an additional component necessary for 
maximum bactericidal effect. Such an adsorbable, heat-labile component 
was proposed earlier for the bactericidal reaction of normal human 
serum against nontypable Haemophilus influenzae (Musher et al., 1983). 
Future studies using various combinations of unadsorbed vs. adsorbed 
and HI vs. unheated sera would be helpful in understanding this 
phenomenon. 
In conclusion, the capsular material on_!'...:.. haemolytica from 
cultures in the logarithmic growth phase appears to enhance resistance 
of the organisms to the bactericidal effect of bovine serum. These 
data indicate that high antibody titers, particularly to capsular 
material, are needed for serum killing of encapsulated organisms to 
occur, whereas decapsulated organisms are readily killed by sera even 
from animals with low antibody titers to the organism. It appears 




INTERACTION OF ENCAPSULATED AND DECAPSULATED 
PASTEURELLA HAEMOLYTICA WITH 
BOVINE PHAGOCYTES 
Introduction 
Pasteurella haemolytica, serotype 1 is the organism which causes 
the acute fibrinous pneumonia associated with shipping fever or 
pneumonic pasteurellosis of cattle (Rehmtulla and Thompson, 1981). 
The organisms are commonly found in the upper respiratory tract, but 
not in the lungs, of healthy cattle (Magwood et al., 1969). Protection 
of the lung normally involves phagocytosis of organisms by resident 
alveolar macrophages or recruited polymorphonuclear leukocytes (PMN). 
However, when an animal is stressed, the organism often overwhelms the 
normal defense mechanisms and multiples rapidly in the lung, producing 
pneumonia and sometimes death (Collier, 1968). The cause of breakdown 
of the defense system against.!'....!._ haemolytica is not clearly understood. 
Various groups of investigators have reported wide variations in 
the extent of phagocytosis of.!'....!._ haemolytica by pulmonary macrophages, 
which are generally considered to be the first line of defense against 
inhaled organisms. One group using logarithmic-phase cultures of .!'....!._ 
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haemolytica was unable to demonstrate uptake of C-labelled organisms 
(Walker et al., 1980). Another group using formalin-killed 18-hr 
cultures reported that.!'....!._ haemolytica was poorly phagocytized by 
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cultured bovine alveolar macrophages (Markham and Wilkie, 1980). The 
addition of immune serum enhanced uptake somewhat. Those authors 
suggested that when large numbers of organisms are presented to the 
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lung following stress-related depression in macrophage function, the 
bacteria themselves may further impair macrophage viability and phago-
cytosis. Others (Maheswaran et al., 1980) have reported high levels of 
phagocytosis of l:.!._ haemolytica by bovine alveolar macrophages adhered 
to plastic. Up to 15% of stationary-phase organisms were reportedly 
phagocytized without prior opsonization, and 90-95% of organisms were 
phagocytized after opsonization with normal or immune serum, respectively. 
Perhaps the difference between results from these groups derives from 
the age of the cultures utilized. Berggren et al. (1981) compared the 
interaction of bovine .PMN with logarithmic- and stationary-phase 
cultures of l:.!._ haemolytica opsonized with normal bovine serum or anti-
serum. They found that only 5-8% of logarithmic-phase organisms were 
phagocytized, whereas 90-98% of stationary-phase organisms were phago-
cytized at bacteria:PMN ratios of 10:1. 
Many important pathogenic bacteria possess capsular or cell wall 
components which inhibit phagocytosis (Karakawa and Young, 1979; 
Densen and Mandell, 1980; Hill et al., 1983; William et al., 1983). 
In many such organisms, resistance to phagocytosis is considered to 
be their main virulence mechanism (Smith, 1977). Capsular material 
has been shown to prevent efficient phagocytosis of Pasteurella multocida 
by bovine PMN unless hyperimmune serum was used as an opsonic source 
(Maheswaran and Thies, 1979). Enzymatic decapsulation of the organisms, 
however, rendered them susceptible to phagocytosis. Physical reduction 
of the amount of capsular material on one strain of Klebsiella pneumoniae 
was also found to increase its susceptibility to opsonization and 
subsequent phagocytosis (Williams et al., 1983). 
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R.=.. haemolytica from logarithmic-phase cultures have been reported 
to be encaps~lated, whereas stationary-phase cultures were composed 
mainly of n~nencapsulated organisms (Corstvet et al., 1982a). The 
difference in capsule content of organisms from cultures at different 
stages of the growth cycle may have a bearing upon their reported 
difference in resistance to phagocytosis. The purpose of the present 
study was to compare the interactions of encapsulated and decapsulated 
R.=.. haemolytica with bovine phagocytes. Differences in opsonization by 
immune and nonirnmune sera, extent of phagocytosis, fate of internalized 
organisms and cytotoxicity of organisms for phagocytes were examined. 
The findings are discussed in terms of a possible role for capsular 
material in resistance of R.=.. haemolytica to phagocytosis by bovine 
phagocytes. 
Materials and Methods 
Microorganism 
The organism used throughout the study was.!'....:._ haemolytica, biotype 
A, serotype 1 originally isolated'from. a feedlot calf (Corstvet et al., 
1973). The bacteria were maintained in the lyophilized state. The 
organisms were grown on a modified Sawata's medium (Kume et al., 1978), 
and suspensions of both encapsulated organisms (EO) and decapsulated 
organisms (DO) were prepared iri phosphate buffered saline (PBS) by the 
methods outlined in Chapter IV. 
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Sera 
The six bovine sera used in the serum bactericidal assays were used 
in these studies also (Chapter IV). The sera are designated as follows: 
anti-live serum (AL), anti-capsular serum (AC), fetal bovine serum (FBS), 
unexposed serum, and natural exposure A and B serum. Measurement of 
direct bacterial agglutination titers,and serum antibody titers to 
somatic antigens or to a capsular extract off..:_ haemolytica were 
performed as described in Chapter IV. All sera utilized in these studies 
had been heat-inactivated by incubation at 56° C for 30 min. 
Samples of AL and AC sera were preadsorbed by incubation with 
formalin-killed DO as in Chapter IV. Crude IgG fractions of AL and 
AC sera were also prepared by (NH4) 2so4 precipitation as described in 
Chapter VI. 
Chicken antiserum was prepared against f..:_ haemolytica cytotoxin-B 
as described previously (Gentry et al., 1982). 
Bovine Phagocyte Preparation 
Polymorphonuclear leukocytes (PMN) were collected from heparinized 
blood from healthy cattle on Ficoll-Paque (Pharmacia, Piscataway, NJ) 
as described in Chapter VI. Pulmonary alveolar macrophages (PAM) were 
collected from healthy cattle bybronchoalveolar lavage as described 
previously (Corstvet et al., 1982b). Suspensions of the phagocytes in 
RPMI 1640 tissue culture medium (GIBCO Laboratories, Grand Island, NY) 
were prepared as related in Chapter VI. 
Opsonization of Organisms and Phagocytosis Assay 
Opsonization and phagocytosis assays were performed by a 
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modification of the method of Rush et al. (1981) in sterile 5 ml 
siliconized glass tubes. Opsonization mixtures consisted of 0.04 ml of 
7 8 appropriate bacterial suspension containing 5 x 10 to 2 x 10 colony-
forming-units (CFU)/ml, 0.1 ml of RPMI i640, and 0.1 ml of bovine serum. 
The mixtures were incubated for 15 min on a shaking platform in a 37° C 
water bath. To each tube, 0.4 ml of a suspension of bovine phagocytes 
was then added at organism to cell ratios ranging from 4: 1 to 45: 1. The 
tube contents were vigorously mixed for 5 sec on a vortex mixer 
(Scientific Products, Inc., Bohemia, NY) and 0.1 ml of the mixture was 
immediately withdrawn and added to 9.9 ml of PBS at 4° C for a zero time 
(T0) viable count sample. All tubes were held on ice until the phago-
cytes could be added to each one. When all additions had been completed, 
the tubes were incubated again for 15 min at 37° C as described 
previously to allow phagocytosis to occur. The tubes were then centri-
fuged at 4° C for 10 min at 115 x g to separate the phagocytes from 
unphagocytized organisms (differential centrifugation). The supernatants 
were carefully removed with a Pasteur pipette and discarded. The cell 
pellets were washed three times in cold PBS (4° C) with differential 
centrifugation between washes. Supernatants from the washes were 
aspirated and discarded. The f~nal phagocyte pellets were resuspended 
in RPMI 1640 to their original volume (6.9 ml). From each tube, a 0.1 
ml sample was removed and added to a separate 9.9 ml volume of cold 
distilled water (4 ° C) containing O .01%_ gelatin (Eastman Kodac Co., 
Rochester, NY). The gelatin-water samples were then vigorously mixed 
for 15 sec on a vortex mixer to lyse the phagocytes, and held on ice 
for viable counts designated "Lyl." All samples on which counts were 
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performed were held on ice until viable counts could be performed by a 
spot-plate technique after serial dilutions of the samples in PBS. 
Calculation of% phagocytosis was ·determined by the following 
formula: 
% Phagocytosis ( 
CFU/ml in Lyl sample - ) x 100 
CFU/ml in T0 sample 
An experiment was performed to verify the validity of the 
differential centrifugation and viable counting techniques as a measure 
of% phagocytosis. The method followed was that of van Furth and van 
Zwet (1978). The experimental design was essentially the same as 
described previously, except that six different viable count measurements 
were performed as follows: 
Sample A--Same as T0 count above, 0.1 ml of mixture of organisms 
and phagocytes before incubation added to 9.9 ml of PBS 
to determine initial number of CFU/ml. 
Sample B--0.1 ml of mixture of organisms and phagocytes after 
incubation added to 9.9 ml of distilled water to determine 
total number of CFU/mL 
Sample C--0.1 ml of same mixture as in Sample B added to 9.9 ml of 
PBS to determine number of CFU/ml of extracellular 
organisms only. 
Sample D--0.1 ml of resuspended phagocyte pellets after final 
differential centrifugation wash added to 9.9 ml of PBS 
to determine number of pellet-associated extracellular 
CFU/ml. 
Sample E--0.1 ml of same suspension as in Sample D added to 9.9 ml 
of distilled water to determine total number of pellet-
associated CFU/ml. 
In these experiments, results were compared of% phagocytosis as 
calculated by three different methods as follows: 
Method 1:* % phagocytosis ( CFU/ml in Sample E CFU/ml in Sample A) x lOO 
Method 2: ( CFU/ml in Sample E % phagocytosis = ) x 100 
CFU/ml in Sample B 
Method 3: % phagocytosis = 
( CFU/ml in Sample E - CFU/ml in Sample D) x lOO 
CFU/ml in Sample B 
* Method used in original experiments 
Additional calculations were performed as follows: 
Measurement of Agglutinated 
CFU/ml in Sample D Organisms in Cell Pellet 
Measurement of Intracellular 
CFU/ml in Sample B -Organisms After Phagocytosis 
CFU/ml in Sample c Incubation 
Measurement of Intracellular 
CFU/ml in Sample E -Organisms After Differential 
Centrifugation CFU/ml in Sample D 
Fate of Phagocyte-Associated Organisms 
Experiments were performed using 'resuspended phagocytic cells 
after the final wash step of the opsonization and phagocytosis assays. 
After removal of the Lyl viable count samples, the tubes of suspended 
phagocytes were incubated for 60 additional min on a shaking platform 
in a 37° C water bath. From each tube, a 0.1 ml sample was removed 
after 30 min and again after 60 min, and added to a separate 9.9 ml 
volume of ice-cold 0.01% gelatin-water. The gelatin-water samples 
were vigorously mixed for 15 sec on a vortex mixer to lyse the 
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phagocytes and held on ice for viable count measurements designated 
"Ly2" and "Ly3" respectively. Viable count measurements were performed 
as described previously. Calculations of change in viability of cell-
associated organisms were determined by the following formulas: 
Change in viability of cell-
associated organisms after 30 min 
( CFU/ml in Ly2 Sample CFU/ml in Lyl Sample) x 100 
CFU/ml in Lyl Sample 
Change in viability of cell-
associated organisms after 60 min = 
( CFU/ml in Ly3 Sample CFU/ml in Lyl Sample) x 100 
CFU/ml iri Lyl Sample 
In several experiments, attempts were made to prevent growth of 
any extracellular cell-associated organisms; 25-100 units/ml of Penicillin 
plus 25-100 µg/ml of Streptomycin (Pen-Strep, GIBCO Laboratories, Grand 
Island, NY) were added to the RPMI 1640 medium that was used to resuspend 
the phagocyte pellets after the final wash by differential centrifugation. 
Toxicity of Organism for Phagocytes 
Determination of viability of phagocytes was performed concurrently 
with the measurements of fate of cell-associated organisms using the 
same phagocyte suspensions. Thus at the time of removal of the Lyl, 
Ly2, and Ly3 samples (0, 30, and 60 min), an additional 0.1 ml sample 
of each phagocyte suspension was removed and added to a separate 0.1 
volume of cold RPMI 1640. The tubes were held on ice for trypan blue 
exclusion determinations of phagocyte viability. Immediately before 
each sample was counted, 0.1 ml of 0.4% trypan blue (GIBCO Laboratories, 
Grand Island, NY) was added, and 200-300 cells were examined micro-
scopically for viability using a hemacytometer. 
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Once again, in certain experiments various concentrations of Pen-
Strep were added to the RPM! medium in an attempt to prevent growth of 
extracellular organisms (and thus preclude cytotoxin formation. In 
still other experiments, the RPM! 1640 used to resuspend the phagocytes 
was supplemented with 33% chicken anti-cytotoxin B serum as a means of 
protecting the phagocytes from cytotoxin produced in situ. 
Preparation of Samples for Transmission 
Electron Microscopy 
Samples of pulmonary alveolar macrophages (PAM) in RPM! 1640 
processed through the final wash step of the opsonization and phago-
cytosis assay using encapsulated organisms and AL serum, were centrifuged 
at 15,000 rpm in a microcentrifuge (Epperdorf Co., Hamberg, West Germany) 
and resuspended in cacodylate-buffered 1% glutaraldehyde (Electron 
Microscopy Sciences, Ft. Washington, PA) for 1 hr. The cells were then 
washed in three 15 min changes of cacodylate buffer, post-fixed for an 
additional 1 hr in 2% osmium tetroxide (Stevens Metallurgical Corp., 
New York, NY), and dehydrated in a graded ethanol series. The dehy-
drated cells were embedded in Polybed (Polysciences Inc., Warrington, 
PA). Ultrathin sections were stained with uranyl acetate and lead 
citrate and examined with a Phillips 200 transmission electron micro-
scope. 
Statistical Analysis 
Comparisons of% phagocytosis to agglutination titers or to FIAX 
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titers of the sera used for opsonization were performed by linear 
regression analysis, as were comparisons of% decrease in phagocyte 
viability to% phagocytosis or to% increase in CFU/ml of phagocyte 
suspensions (Bailey, 1981) •. Cytotoxicity of EO and DO for PAM were 
compared by Student's t-test. 
Results 
Opsonization and. Phagocytosis Assays 
When phagocytic capacity of PMN and PAM were compared in experi-
ments with the same kind of organisms opsonized with the same antiserum, 
the% phagocytosis was consistently 1.1-2.5 times higher when PAM were 
used than when PMN were used (Table 5.1). 
TABLE 5.1 
COMPARISON OF PHAGOCYTOSIS BY BOVINE PMN AND PAM 
Avg. Avg. 
% % Avg. % 
Phagocytosis Phagocytosis with PAM 
Organism Serum In PMN In PAM Avg.% 
Used Used Experiments Experiments with PMN 
Encapsulated FBS 0.4 ( 4) 1.0 ( 4) 2.5 
Decapsulated FBS 0.8 (4) 1.8 ( 4) 2.2 
Encapsulated AL 23 .1 (4) 49.9 (16) 2.2 
Decapsulated AL 6.6 (4) 14.0 ( 6) 2.1 
Encapsulated AC 143.0 (4) 160.3 (10) 1.1 
Decapsulated .AC 9.0 (4) 16.1 ( 7) 1.8 
Note: () indicates number of trials averaged. 
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FBS was a poor opsonin for either EO or DO, allowing for less than 
2% phagocytosis by PMN or PAM, whereas opsonization with AL or AC serum 
increased phagocytosis of both EO and DO (Table 5.1). In experiments 
where EO and DO were compared after opsonization by AL serum, the% 
phagocytosis of EO was 2.0 and 3.5 times higher than that calculated for 
DO, using PAM and PMN respectively. Using AC serum, the average% 
phagocytosis caiculated for EO was 9.8 and 10.0 times higher than that 
calculated for DO, using PAM and PMN respectively (data used to calcu-
late% phagocytosis for EO were taken only from experiments in which both 
cell types were used). Overall, when AL and AC sera were used with 
either type of phagocyte, DO appeared to be opsonized equally well by 
both sera, whereas EO appeared to be opsonized 3.2-4.2 times better 
by AC serum than by AL serum. 
Phagocytosis of EO by PAM was studied· following opsonization with 
IgG fractions and preadsorbed sera obtained from AL and AC sera (Figure 
5.1). The IgG fraction from AC serum opsonized EO as efficiently as the 
parent serum, whereas phagocytosis of organisms opsonized with the IgG 
fraction of AL serum was approximately 64% of that calculated when the 
native serum was used. Preadsorption of AL serum with formalin-killed 
DO only slightly reduced its apparent opsonizing capacity for EO, 
whereas preadsorption 9f AC serum with·formal:i,.n-killed DO reduced the 
calculated% phagocytosis by approximately 89% (Table 5.2). 
The% phagocytoses of EO by PAM after opsonization with unexposed, 
natural exposure A and natural exposure B sera are found in Table 5.2. 
The% phagocytosis after opsonization with unexposed serum was lower 
than that after opsonization with either natural exposure serum. 
Figure 5.1. Calculated% Phagocytosis with Macrophages Using Treated 
Se~a to Opsonize Encapsulated Organisms. Comparison 
of% phagocytosis by bovine macrophages of encapsulated 
organisms opsonized by anti-live or anti-capsular 
native serum, preadsorbed serum, or serum IgG fraction. 
Preadsorbed sera were preincubated for 30 min at 4° C 
with decapsulated organisms. Serum IgG fractions were 
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TABLE 5.2 
COMPARISON OF IMMUNOASSAYS FOR CRUDE IgG FRACTIONS AND 
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Sera preadsorbed with formalin-killed decapsulated organisms. 
Regression analyses were performed between% phagocytosis and 
three other immunological measurements of antibody to R..=.. haemolytica 
(Table 5.2). % phagocytosis correlated positively (r = 0.9794, 
p < 0.001) with the direct bacterial agglutination titer of the sera, 
but did not correlate with the FIAX titer to formalin-killed P. 
haemolytica (r = 0.6887, p > 0.05) or to the FIAX reaction to P. 
haemolytica capsular extract (r = 0.3211, p > 0.2). 
To determine if agglutinated organisms were being pelleted with 
phagocytes during differential centrifugation, an experiment was 
performed using PAM and either EO or DO opsonized with FBS, AL serum 
or AC serum. The % phagocytosis was calculated by thre,= ciifferent 
methods (Table 5.3). A comparison of methods 1 and 2 was made to 
determine the contribution of increase in viable count of the organism 
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suspension during opsonization to the calculated% phagocytosis. The 
% phagocytoses calculated by the two methods were comparable for all 
samples except EO opsonized with AC serum. A comparison of method 3 to 
method 2 was made to determine the contribution of agglutinated organisms 
to the calculated% phagocytosis. Calculation by method 3 could not be 
performed using DO and AL serum. For four of the other five samples, 
the% phagocytosis calculated by method 2 and method 3 were comparable. 
In the sample using DO and AC serum, the% phagocytosis calculated by 
method 3 was considerably less than that calculated by method 2. 
TABLE 5 .3 
COMPARISON OF% PHAGOCYTOSIS CALCULATED BY THREE DIFFERENT METHODS 
% Phagocytosis Calculated By 
Organisms Serum Method l* Method 2 Method 3 
Encapsulated FBS 0.9 0.4 0.03 
Decapsulated FBS 1.4 1.6 0.65 
Encapsulated AL 38.2 45.2 41.9 
Decapsulated AL 8.8 8.4 NC,i 
Encapsulated AC 111.1 50.0 48.0 
Decapsulated AC 16.4 20.3 9.2 
* Method used in original studies. 
,i-Not calculated--viable count D was higher than viable count E. 
The number of viable extracellular, PAM-associated organisms was 
found to be approximately the same for all samples opsonized with AL or 
AC s~ra (Table 5.4). The number of such organisms in the samples 
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opsonized with FBS was 0.3 to 1.0 log units less than any of the samples 
opsonized with antiserum. The number of viable intracellular organisms 
as determined by CFU/ml after the phagocytosis incubation, was 
approximately 1.0-1.5 log units higher for EO opsonized with antisera 
than for any of the other samples. The number of viable intracellular 
organisms aft~r the final wash of the di~ferential centrifugation was 
approximately 0.2-1.0 log units higher for EO opsonized with antisera 
than for any of. the other samples. 
TABLE 5. 4 
COMPARISON OF EXTRACELLULAR AND INTRACELLULAR PAM-ASSOCIATED ORGANISMS 
CFU/ml of 
Extracellular 
PAM- CFU/ml of CFU/ml of 
Associated Intracellular Intracellular 
Organisms Serum Organisms Organisms I* Organisms I** 
Encapsulated FBS 1. 2x10 5 1.0xlO 4 2 .OxlO 6 
Decapsulated FBS 
. 4 
4.-0xlO 2.8x10 4 4 .OxlO 5 
Encapsulated AL 3 .OxlO 
5 3. 9x10 6 4 .OxlO 6 




Encapsulated AC 4.lxlO 
5 9.6x10 6 1. 7x10 7 
Decapsulated AC 
'5 
4. 2xl0 3 .5x10 5 1. lxlO 6 
* Calculated by measurements taken at end of phagocytosis incuba-
tion. 
** Calculated by measurements taken after final wash of differential 
centrifugation. 
*** NC= Not calculated--viable count D was higher than viable count E. 
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A comparison of the number of extracellular phagocyte-associated 
and viable intracellular organisms after differential centrifugation 
revealed that in the samples containing EO opsonized with either AL or 
AC serum, the number of intracellular organisms calculated was 1.0-1.5 
log units higher than the number of extracellular organisms (Table 5.4). 
In all of the other samples, the number of CFU/ml was found to be 
slightly higher for extracellular than for intracellular organisms. 
A comparison of the number of calculated intracellular organisms in 
the samples after the phagocytosis incubation step with the number 
calculated after the final wash by differential centrifugation, revealed 
a decrease for all samples of from 0.1 to. 2.5 log units. 
Fate of Phagocyte-Associated Organisms 
The viable count of phagocyte-associated organisms in phagocyte 
suspensions after differential centrifugation increased after an 
additional incubation period, regardless of what combination of 
phagocyte, organism, and antiserum was used (Table 5.5). There was no 
apparent consistent difference in extent of growth between EO and DO. 
Addition of 25 units/ml of Penicillin and 25 µg/ml of Streptomycin to 
the incubation medium reduced the extent of organism proliferation in 
all samples. An increase in, antibiotic concentration to 100 units/ml 
Penicillin and 100 µg/ml Streptomycin provided essentially the same 
result. 
In samples using EO plus AC serum or DO plus AL serum, a viable 
count decrease occurred when antibiotics were added to the medium. In 
the other samples, viable count increases occurred (Table 5.5). 
TABLE 5.5 
CHANGE IN CFU/ml OF SUSPENSIONS OF PHAGOCYTES 





After 60 min After 60 min 
Incubation Incubation 
Without With 
Phagocytes Organisms Serum Antibiotics Antibiotics 
PMN Encapsulated FBS +164 (3) NT 
PMN Decapsulated FBS +159 (3) NT 
PMN Encapsulated AL +199 (2) +169 (1) 
PMN Decapsulated AL +68 (2) -72 (1) 
PMN Encapsulated AC +109 (2) -15 (1) 
PMN Decapsulated AC +572 (2) +75 (1) 
PAM Encapsulated FBS +156 (4) NT 
PAM Decapsulated FBS +186 (4) NT 
PAM Encapsulated AL +886 (9) +285 (4) 
PAM Decapsulated AL +244 (4) -27 (2) 
PAM Encapsulated AC +154 (6) -37 (3) 
PAM Decapsulated AC +859 (4) +52 (3) 
Note: NT Not tested; ( ) indicates number of trials averaged. 
Transmission electron microscopy was performed on PAM suspensions 
after phagocytosis of EO opsonized with AL serum. Extracellular 
organisms were seen as well as organisms in various stages of degen-
erationwithin phagocytic vacuoles (Figures 5.2 and 5.3). Both viable 
and degenerated PAM were present. 
Cytotoxicity of Encapsulated and Decapsulated 
Organisms for Phagocytes 
Phagocyte viability decreased during a 60 min post-phagocytosis 
incubation of all samples (Table 5.6). EO and DO were equally toxic 
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Figure 5.2. Electron Micrograph of Pulmonary Alveolar Macrophage 
Phagocytizing Encapsulated Organisms. Undegraded 
organisms may be seen within membrane-bound 
phagocytic vacuoles (x 31,250). 
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Figure 5.3. Electron Micrograph of Pulmonary Alveolar Macrophage 
Degrading Phagocytized Encapsulated Organisms. 
Electron micrograph of bovine macrophage after 
phagocytosis of encapsulated organisms. Organisms 
are in various states of degradation within phago-
cytic vacuoles. Intact extracellular encapsulated 
organisms are also present (x 24,750). 
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TABLE 5.6 
DECREASE IN PHAGOCYTE VIABILITY DURING POST-PHAGOCYTOSIS INCUBATION 
% % % % 
Phagocytes Phagocytes Decrease in Decrease 
Viable Viable After Viability in 
Before 1-hr Without Viability With 
Phagocytes Organisms Serum Incubation Incubation Antibiotics Antibiotics Added 
PMN Encapsulated FBS o~o (2) No cells seen (2) NT 
PMN Decapsulated FBS 0.0 (2) No cells seen (2) NT 
PMN Encapsulated AL 84.9 (3) 24.0 (2) 60.9 (2) 59.7 (1) 
PMN Decapsulated AL 85.2 (3) 19.9 (2) 65.3 (2) 58.5 (1) 
PMN Encapsulated AC 73.2 (3) 23.7 (2) 49.5 (2) 48.6 (1) 
PMN Decapsulated AC 78. 1 (3) 24.8 (2) 53.2 (2) 42.8 (1) 
PAM Encapsulated FBS 49.5 (4) 32.1 (4) 16.9 (4) NT 
PAM Decapsulated FBS 69.8 (4) 54.8 (4) 15.0 (4) NT 
PAM Encapsulated AL 60.2 (10) 25. 6 (10) 34.6 (10) 27.9 (4) 
PAM Decapsulated AL 67.3 ( 4) 54.4 (4) 12.9 (4) 11. 2 (2) 
PAM Encapsulated AC 70. 2 (7) 29.9 (7) 40.3 (7) 39.0 (3) 
PAM Decapsulated AC 70.7 (4) 42.7 (4) 28.0 (4) 14. S- (3) 
Note: NT= Not tested; ( ) indicates number of trials averaged. 
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to PMN using all sera tested. EO were more toxic to PAM than were DO 
after opsonization by AL or AC serum, but not after opsonization with 
FBS. The difference was statistically significant (p = 0.04) in samples 
using AL serum, but was not significant (p = 0.06) in samples using 
AC serum. In parallel samples both EO and DO were more toxic for PMN 
than for PAM. Live PMN could not be found in sa~ples,using either EO 
or DO opsonized with FBS. Addition of Pen-Strep to the incubation 
medium slightly reduced the% decrease in viability for all samples 
tested (Table 5.6). In no case did Pen-Strep completely prevent 
phagocyte death. In an experiment in which PAM were incubated with 
EO opsonized with AL serum, supplementation of the incubation medium 
with 33% chicken anti-cytotoxin-B serum reduced the% decrease in 
viability by 6.5% but did not prevent macrophage death (data not shown). 
Discussion 
Phagocytosis studies were carried out using both bovine PMN and PAM. 
Following opsonization with a particular serum, the% phagocytosis of 
l.:_ haemolytica was consistently higher for PAM than for PMN. In 
studies where human phagocytes were compared, PMN phagocytized better 
than blood monocytes (Horwitz and Silverstein, 1980; Mezzatesta and 
Rest, 1983), but not better than alveolar macrophages when certain types 
of organisms were used (Hof et al., 1980). Electron micrographs of 
phagocytes obtained during the present studies revealed that internalized 
organisms were being degraded during the assay. Because PMN are 
apparently more efficient than macrophages at killing microorganisms 
(Densen and Mandell, 1980), perhaps the lower viable counts used to 
calculate% phagocytosis in the present studies reflected a higher 
percentage of killing of internalized bacteria by PMN during the assay. 
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Neither PAM nor PMN were found to be capable of effective phago-
cytosis of EO or DO opsonized by heat-inactivated FBS containing no 
demonstrable antibody to Pasteurella haemolytica. Opsonization of EO 
with heat-inactivated AL or .AC sera enhanced phagocytosis of these 
organisms by both cell types. In fact,% phagocytosis of EO with AC 
serum was consistently calculated to be over 100%, presumably due to 
multiplication of the organisms during the opsonization and phago-
cytosis incubation periods. Similar bacterial multiplication most 
likely could not occur with DO opsonized with either antiserum or with 
EO opsonized with AL serum, due to the bacteriostatic effect of these 
sera for those organisms (see Chapter IV). This difference in serum 
bacteriostatic effects could account for the observation that AC serum 
appeared to be a better opsonin than AL serum for EO, even though AL 
serum has a higher antibody titer to formalin-killed R..:_ haemolytica 
organisms as well as to capsular extract (see Chapter IV). 
Calculated·% phagocytosis was low for DO even after opsonization 
with AL or AC sera, both of which were shown by agglutination studies 
to contain antibodies for the DO cell surface. This was an unexpected 
result because in many previous studies using other organisms, nonen-
capsulated or decapsulated organisms were found to be phagocytized more 
efficiently than encapsulated organisms (Maheswaran and Thies, 1979; 
Horwitz and Silverstein, 1980; Williams et al., 1983). Only one early 
study suggested that decapsulated Group A Strepococci retained their 
resistance to phagocytosis by human leukocytes (Rothbard, 1948). The 
viable count technique used in the present study did not take into 
account any potential differences in bactericidal activity of sera or 
intracellular killing rates of internalized encapsulated versus 
decapsulated organisms. If, for instance, decapsulation of organisms 
makes them.more susceptible to rapid intracellular killing, low viable 
counts of cell-associated organisms would be misinterpreted as reduced 
phagocytosis. Use of radioactively-labelled organisms, whose label 
would be retained within the phagocytes upon bacterial death, along 
with viable count techniques would permit differentiation of the two 
interpretations and might provide a more realistic comparison of% 
phagocytosis of encapsulated versus decapsulated organisms. 
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In several studies it has been shown that encapsulated bacteria 
require both specific antibody and complement for effective opsonization, 
whereas nonencapsulated organisms can be opsonized by complement alone 
(Rothbard, 1948; Verbrugh et al., 1979; Horwitz and Silverstein, 1980). 
Only heat-inactivated sera were used in the present studies because both 
AL and AC sera were found to be bactericidal for the organisms when they 
contained complement components (see Chapter IV). Also, in studies 
using R...=_ multocida, heat-inactivated antisera had been shown to opsonize 
organisms essentially as well as complement-rich sera (Maheswaran and 
Thies, 1979; Rush, 1981). However, use of fresh, unheated nonimmune 
serum as an opsonin for EO and DO should be performed in the future 
to determine the opsonizing effects of complement on the two cell types 
in the absence of specific antibody. 
Crude IgG fractions of AC and AL sera effectively opsonized EO for 
phagocytosis by PAM, indicating that the opsonizing capacity of these 
sera resides in their (NH4) 2so4-precipitable fractions. Another 
indication that the opsonizing capacity of various sera for EO is due 
to their specific antibodies to the organism is the high positive 
correlation between opsonizing capacity of the sera and their aggluti-
nation titers. 
Results of opsonization and phagocytosis assays performed using 
antisera that were preadsorbed with DO were much like those found for 
the bactericidal activity of the sera (see Chapter IV). Preadsorption 
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of AL serum did not reduce its FI.AX titer to formalin-killed organisms 
and also only slightly reduced its bactericidal and opsonizing capacities 
for EO. Preadsorption of AC serum, on the other hand, reduced its FIAX 
titer to formalin-killed organisms by 47.4% and also drastically reduced 
its bactericidal and opsonizing capacities by 100% and 89%, respectively. 
Results of the experiment utilizing additional viable count samples 
confirmed that the method used to calculate% phagocytosis in these 
studies was valid. In future studies, the T0 counts should be performed 
both before and after the phagocytosis incubation period. Such an 
approach would permit detection of differences between samples with 
respect to ability of the organisms to multiply within the phagocytosis 
mixture. It does not appear that agglutinated organisms constitute a 
major component of the high calculated% phagocytosis seen with EO 
opsonized with AL and AC sera, because the number of intracellular 
pellet-associated organisms in those samples was 1.0 to 1.5 log units 
higher than the number of extracellular pellet-associated organisms. 
In the other samples, the number of intracellular and extracellular 
pellet-associated organisms was approximately equal. Cohn and Morse 
(1959) similarly determined after a number of control studies with 
staphylococci and PMN, that bacterial agglutination was not a major 
problem in determining phagocytosis and intracellular killing. 
Cohn and Morse (1959) also reported that phagocytosis was followed 
by rapid inactivation of the organisms. Maheswaran et al. (1980) 
likewise found that~ haemolytica phagocytized by PAM were rapidly 
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degraded. In the present studies, reduction of the calculated number of 
intracellular organisms for all samples after differential centrifu-
gation corroborated the electron microscopic evidence indicating degra-
dation of internalized organisms. Nevertheless, the number of viable 
organisms in incubated suspensions of phagocytes after phagocytosis 
and differential centrifugation consistently increased. This was most 
likely due to growth of extracellular organisms. In an in vitro study 
using~ multocida, Collins et al. (1983) found that mouse alveolar 
macrophages only slowly inactivated phagocytized organisms, so that 
survivors later multiplied extensively. Those workers hypothesized 
that the surviving organisms probably were not killed because they were 
cell-associated rather than fully phagocytized. However, in the present 
studies, growth of extracellular organisms was presumably inhibited by 
addition of Pen-Strep, but the viable count still. increased for half 
of the samples and was only moderately decreased in others. These 
data indicate that multiplication of organisms may also be occurring 
within the phagocytes. During the incubation period a 13-61% decrease 
in viability of the phagocytes occurred. Organisms sequestered 
within dead or dying phagocytes could conceivably be protected from 
the bactericidal effects of antibiotics in the incubation medium; such 
organisms presumably would be capable of multiplication within this 
protected environment. However, no correlation could be established 
between% phagocytosis or% increase in CFU/ml of the phagocyte 
suspensions and % decrease in phagocyte viability (p > 0 .05). 
Maheswaran et al. (1980) reported previously that at low 
bacteria/PAM ratios (10:1 or less), there was phagocytosis and killing 
of~ haemolytica but no cytotoxic changes in the PAM. At bacteria/PAM 
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ratios of 20:1 or higher, however, approximately 10% of the bacteria 
were not phagocytized and thus replicated and released a substance that 
was toxic for PAM. Markham and Wilkie (1980) reported that when large 
numbers of formalin-killed R.!. haemolytica were added to cultured PAM, 
there was a positive correlation between increasing uptake of bacteria 
and loss of PAM from coverslips to which they were attached. Those 
authors indicated that some property inherent even to killed P. 
haemolytica accounted for the toxicity. The bacteria/phagocyte ratios 
used in the majority of the studies described herein was between 10:1 
and 20:1. The% decrease in phagocyte viability was more pronounced 
with PMN than with PAM. Addition of antibiotics or antiserum that 
neutralizes R.!. haemolytica cytotoxin to the incubation medium did not 
prevent phagocyte death. This indicates that killing was not due solely 
to multiplication and cytotoxin production by extracellular organisms. 
The decrease in phagocyte viability may have been due to a combination 
of damage caused by internalized organisms and cytotoxin produced by 
extracellular, phagocyte-associated organisms. Future studies should 
include determinations of change in number of viable intracellular 
organisms versus extracellular ones in phagocyte suspensions following 
incubation. Such an approach would help to clarify the contribution 
each makes to phagocyte death. 
In conclusion, in these studies phagocytosis of logarithmic-phase 
R.!. haemolytica by bovine PAM and PMN was shown to occur in the presence 
of specific anti-capsular antibodies. Encapsulation of the organisms 
was not shown to enhance their resistance to phagocytosis. Neither 
EO nor DO were effectively phagocytized in heat-inactivated FBS. 
When opsonized by sera containing specific antibodies to the organisms, 
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EO appeared to be more easily phagocytized than their decapsulated 
counterparts. Intracellular degradation of organisms was shown by 
transmission electron microscopy. However, by a viable count technique, 
intracellular killing of neither EO nor DO could be demonstrated, and 
a difference in susceptibility between the two types of organisms to 
killing by phagocytes was not established. 
Exposure of bovine phagocytes to~ haemolytica was shown to result 
in death of both PMN and PAM. PMN were somewhat more susceptible than 
PAM to the toxic effects of the organisms. EO appeared to be more 
toxic than DO for PAM, whereas the two types of organisms were equally 
toxic for PMN. A trend could be seen between% phagocytosis by PAM 
and the% decrease in PAM viability upon incubation, although signifi-
cance could not be established mathematically. 
Additional experiments need to be performed using viable counts 
plus accumulation of radioactively-labelled organisms within phagocytes 
before conclusions should be made about comparisons of phagocytic 
capability of bovine PMN versus PAM for~ haemolytica or suscepti-
bility of encapsulated versus decapsulated organisms to phagocytosis. 
CHAPTER VI 
SERUM NEUTRALIZATION OF CYTOTOXIN FROM 
PASTEURELLA HAEMOLYTICA AND COMPARISON 
OF CYTOTOXIN TO EXTRACTED 
CAPSULAR MATERIAL 
Introduction 
Pasteurella haemolytica biotype A serotype 1 has been shown to be 
associated with severe pneumonic pasteurellosis of feedlot cattle 
(Lilli, 1974). Recently a cytotoxin which is toxic for bovine pulmonary 
alveolar macrophages (PAM) and leukocytes (Benson, 1978; Berggren et al., 
1981; Kaehler et al., 1980; Markham and Wilkie, 1980) has been 
demonstrated in supernatant culture fluids obtained during the early 
logarithmic growth phase of the organism (Baluyut et al., 1981). 
Because~ haemolytica exhibits a specificity for disease production in 
ruminants as well as a specificity for cytocidal effects on ruminant 
PAM (Kaehler et al., 1980) and leukocytes (Shewen and Wilkie, 1982), it 
has been suggested that the cytotoxin may be important in the patho-
genesis of bovine pneumonic pasteurellosis (Shewen and Wilkie, 1982). 
Partial characterization of~ haemolytica cytotoxin has demon-
strated it to be a protein (Himmel et al., 1982). Molecular weight 
determ~nations have been variable and attempts to purify it have 
resulted in loss of toxicity (Baluyut et al., 1981; Himmel et al., 1982). 
An association has not been established between cytotoxin and structural 
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components of the organism. However, cytotoxin is produced most 
abundantly during the phase of growth in which the organism is most 
heavily encapsulated (Corstvet et al., 1982a), suggesting that it may 
be of capsular origin. 
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~ haemolytica cytotoxin has been shown to be immunogenic and has 
been suggested as a potential immunizing agent for cattie (Himmel et al., 
1982) in lieu of whole cell bacterins that do not appear to induce 
resistance (Carter, 1957; Friend et al., 1977; Wilkie et al., 1980). 
Its toxicity has been shown to be neutralized by antiserum prepared ·in 
rabbits (Shewen and Wilkie, 1983a), adult bovine serum (Baluyut et al., 
1981; Shewen and Wilkie, 1983b) and bronchoalveolar washings from 
vaccinated calves (Opuda-Asibo et al., 1983). In the present study an 
extract of~ haemolytica capsular material was examined for cyto-
toxicity, and chicken antisera prepared against live P. haemolytica 
organisms, two preparations of cytotoxin,and a capsular extract (CE) 
from the bacterium were compared for their ability to neutralize 
cytotoxin. In addition, sera from several groups of experimental 
calves were tested for cytotoxin neutralizing capacity and the relation-
ship between this capability and resistance of the animals to an 
experimental challenge was examined. 
Materials and Methods 
Organism 
The organism used to prepare all of the bacterial products tested 
was.!:..:_ haemolytica biotype A serotype 1 which was isolated originally 
from a feedlot calf (Corstvet et al., 1973). It was maintained in the 
lyophilized state and was passed periodically in the lungs of 5- to 
8-mo old calves, with reisolation and lyophilization between each 
passage. 
Preparation of Capsular Extract 
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Capsular material was extracted from the organisms as described 
previously (Gentry et al., 1982). Briefly, the bacteria were suspended 
in phosphate buffered saline (PBS, O.OlM, pH 7.2) and the suspension 
was incubated for 1 hr in a shaking water bath at 41 ° C. The organisms 
were removed by centrifugation and the extract consisted of the resulting 
filter sterilized supernatant. For several experiments, CE was concen-
trated 2 to 10 fold either by lyophilization with reconstitution in 
smaller volumes or by ultrafiltration (Amicon hollow fiber concentrator, 
Danvers, MA). 
Preparation of Cytotoxins 
Three different cytotoxin preparations were utilized. Cytotoxin-S 
was prepared by the method of Shewen and Wilkie (1982). Briefly, 
early log-phase organisms were suspended in RPMI 1640 tissue culture 
medium (GIBCO Laboratories, Grand Island, NY) containing 7% fetal bovine 
serum (FBS, Biolabs, Inc., Northbrook, IL), and incubated for 1 hr at 
37° C. The culture was then centrifuged (6000 x g, 15 sec), filter 
sterilized, dialyzed against distilled water, refiltered, and lyophilized. 
Cytotoxin-S-OA was prepared similarly in RPMI 1640 medium containing 
6.4 mg/ml ovalbumin (Sigma Chemical Co., St. Louis, MO) in place of the 
FBS. Cytotoxin-B was prepared by a modification of the method of 
Baluyut et al. (1981) in which the organisms were grown for 6 hr at 
37° C in unsupplemented RPMI 1640 followed by collection and manipu-
lation of the culture supernatant as above. 
Bovine Cell Preparation 
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Polymorphonuclear leukocytes (PMN's) and mononuclear leukocytes 
were collected from heparinized bovine blood on Ficoll-Paque (Pharmacia, 
Piscataway, NJ), The mononuclear leukocytes were removed from the 
interface, washed twice in PBS, and suspended in RPMI 1640 to 5xl06 
cells/ml. The PMN were separated from the erythrocyte pellet by 
hypotonic lysis in distilled water followed by addition of double 
strength PBS to restore tonicity (Mishell and Shiig, 1980). The 
resulting PMN pellet was washed twice in PBS and resuspended to 5xl06 
cells/ml. PAM were collected by bronchioalveolar lavage as described 
previously (Corstvet et al., 1982b). The cells were pelleted by centri-
fugation of the lavage fluids, washed twice in PBS, and resuspended to 
l-5xl06 cells/ml in RPMI 1640. 
Cytotoxicity Assay 
Toxicity of the bacterial products was determined by trypan blue 
exclusion (Mishell and Shiig, 1980). At 5 min intervals, 200 ul of the 
product to be tested was added to 100 ul of a bovine cell suspension in 
a siliconized glass tube. The mixture was incubated for 1-hr at 37° C 
with mild agitation. At the end of the incubation period, 150 ul of 
0.4% trypan blue (GIBCO Laboratories, Grand Island, NY) was added to 
the mixture and 150-300 cells were examined for viability in a 
hemacytometer. Quantitation of killing was described as the percent 
of the total cells remaining viable. 
Serum Samples 
Chicken antisera were prepared by injection of male Cornish cross 
chickens with live P. haemolytica organisms, CE, or cytotoxin as 
described previously (Gentry et al., 1982). Sera were collected also 
from 5- to 8-mo-old beef calves from four experimental groups: 
(1) unvaccinated control animals whose sera had low antibody titers to 
R..:_ haemolytica; (2) unvaccinated animals believed to have been exposed 
naturally because of high antibody titers to the organism; (3) animals 
vaccinated either subcutaneously or intradermally with live~ 
haemolytica type l; and (4) animals vaccinated either subcutaneously 
or intradermally with a commercial bacterin of~ haemolytica type 1 
and P. multocida type A. Vaccinated calves received two intradermal 
or subcutaneous injections at 1 wk intervals of either 5 ml of live 
P. haemolytica organisms (lxl09/ml) or 2 ml of a~ haemolytica and 
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R..:_ multocida bacterin containing an aluminum hydroxide adjuvant (Beecham 
Laboratories, Bristol, TN). Sera were collected immediately prior to 
challenge (21 days after the initial vaccination). Antibody titers to 
formalin-killed P. haemolytica were performed on these sera using a 
quantitative fluorometric immunoassay (FIAX, International Diagnostic 
Technology, Santa Clara, CA) as previously described (Confer et al., 
1983). All calves were challenged by a transthoracic intrapulmonic 
injection of lxlOlO live~ haemolytica in each lung (Panciera and 
Corstvet, 1984). Lesion scores (LS) were calculated for all of the 
experimental calves as previously described (Panciera et al., 1984). 
Briefly, the LS was ascribed to each animal according to specific 
morphologic parameters of the lung lesions induced by the challenge. 
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The scores ranged from Oto 20, with a high LS indicating susceptibility 
and a low LS indicating resistance to challenge. 
Selected sera were adsorbed with formalized decapsulated organisms 
by incubation for 30 min at 37° C. Organisms were then removed by 
centrifugation and the sera filter sterilized. The crude IgG fraction 
of selected sera was isolated by (NH4) 2so4 precipitation by a modifica-
tion of a previously described method (Heide and Schwick, 1978). 
Briefly, euglobulins were removed by dialysis against distilled water 
and centrifugation of the resulting precipitate. The supernatant was 
then treated by dropwise addition of saturated (NH4) 2so4 • The precipi-
tate formed was removed by centrifugation (800 x g, 15 min), resuspended 
in PBS, and reprecipitated. The final precipitate was centrifuged, 
resuspended in PBS to the original serum volume, dialyzed 24 hr against 
PBS, and resterilized by filtration. 
Cytotoxin Neutralization Assay 
All neutralization studies were performed using peripheral blood 
neutrophils as the target cell according to a previously described 
method (Baluyut et al., 1981). Briefly, lyophilized samples of 
cytotoxin-S were reconstituted at 1.5 x concentration with PBS. One 
hundred ul of heat inactivated (56° C for 30 min) serum to be tested 
was added to 200 ul of cytotoxin and the mixture incubated at 37° C 
for 10 min immediately prior to utilization of 200 ul of the mixture 
in a cytotoxicity assay. Daily variations in fragility of the neutrophil 
preparation and in toxicity of a particular vial of cytotoxin were 
compensated for by calculation of a protection index (PI) for each 
serum sample tested by the following formula: 
PI=% PMN's killed using control serum - % PMN's killed using 
test serum I% PMN's killed using control serum 
where% of PMN's killed % alive in control samnle using PBS and 
control serum - % alive in test sample 
using cytotoxin and test serum 
Control serum used was FBS in bovine serum trials and normal chicken 
serum in chicken serum trials. 
In Situ Neutralization Assay 
To determine if the serum neutralization shown with pre-formed 
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cytotoxin could also be accomplished as the toxin was being produced, a 
log phase suspension of R.:_ haemolytica was centrifuged and resuspended 
in RPMI 1640. The suspension was divided into aliquots of 2.7 ml in 
sterile centrifuge tubes and 0.3 ml of heat inactivated serum was added 
to each tube. All tubes were incubated for 1 hr at 37° Cina shaking 
water bath. The bacteria were then removed by centrifugation followed 
by filter sterilization and the filtrates were used in the cytotoxicity 
assay described above. 
Statistical Analyses 
Cytotoxin neutralization (CN) titers and FIAX titers or LS's were 
compared by linear regression analysis (Bailey, 1981). Parameter means 
of treatment groups were compared by Student's t-test. 
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Results 
Comparison of Cytotoxicity of Bacterial 
Products for Bovine Cells 
In the cytotoxicity assay, cytotoxin-S was found to be more toxic 
for PMN and PAM than either cytotoxin-S-OA or cytotoxin-B (Table 6.1). 
Therefore, cytotoxin-S was utilized in the remainder of the studies. 
Comparison of cytotoxin-S to CE for toxicity to PMN's, mononuclear 
leukocytes, and PAM's indicated that cytotoxin-S was toxic for all 
cell types, while CE was no more toxic than was a PBS control (Figure 
6. 1). Concentration of CE (2 to 10 fold)· did not enhance cytotoxicity 
(Figure 6. 2) . 
TABLE 6.1 
COMPARISON OF TOXICITY OF CYTOTOXIN PREPARATIONS 
Number % of Bovine 
Cytotoxin Used of Trials Cells Viable a 
c . ~b ytotoxin-::, 6 29.6 ± 6.3 
Cytotoxin-S-OAc 4 84.2 ± 4.2 
Cytotoxin-Bd 4 74.5 ± 7.0 
'\iean ± standard error of the mean. 
b 
Prepared in medium containing 7% PBS (Shewen and Wilkie, 1982). 
c Prepared as for cytotoxin-S in medium containing 6.4 mg/ml 
ovalbumin. 
d Prepared in unsupplemented medium (Baluyut et al., 1981). 
Figure 6.1. Comparison of Cytotoxicity of Capsular Extract vs. 
Cytotoxin for Bovine Cells. Bars represent% of 
cells viable after incubation for 1 hr at 37° C 



















COMPARl$0N OF CYTOTOXICITY OF CAPSULAR EXTRACT vs. 
CYTOTOXIN FOR BOVINE CELLS 
D CONTROL - PBS 
~ CYTOTOXIN-S - made in RPMI 1,640 + 7% BFS (Shewen, et al.) 
~:::<:3 CAPSULAR EXTRACT - PBS extraction at 41 'll.C for 1 hr. (Gentry, et al.) 
(-#) NO. OF TRIALS AVERAGED 
142 
Figure 6.2. Cytotoxicity of Concentrated Capsular Extract for Bovine 
Neutrophils. Bars represent% of cells viab1e after 
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Because cytotoxin has been shown to be heat labile (Baluyut et al., 
1981) an attempt was made to determine if the 41° C treatment used to 
remove capsular material from the organisms could have destroyed any 
cytotoxic activity in the CE. Heat treatment of several samples of 
cytotoxin-S at 41° C for 1 hr resulted in minimal reduction in toxicity 
(Figure 6.3). 
Neutralization of Cytotoxin-S 
With Chicken Sera 
In order to examine the immunological relationship between CE and 
cytotoxin, serum neutralization assays of cytotoxin-S were performed. 
Only anti cytotoxin-B substantially neutralized cytotoxin-S. 
Antisera to live cells, CE or cytotoxin-S-OA did not neutralize to any 
extent (Table 6.2). 
TABLE 6.2 
NEUTRALIZATION OF CYTOTOXIN-S WITH CHICKEN ANTISERA 
Antiserum Useda 
Chicken anti whole organisms 
Chicken anti capsular extract 
Chicken anti cytotoxin-S-OA 
Chicken anti cytotoxin-B 
aAll antisera were heat-inactivated. 









0.05 ± 0.04 
0.03 ± 0.015 
0 .16 ± 0.04 
0 .96 ± 0.025 
Figure 6.3. Effect of Capsular Extraction Procedure on Toxicity 
of Cytotoxin-S. Bars represent% of cells viable 
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Neutralization of Cytotoxin-S With 
- Bovine Sera 
Although the bovine sera used varied considerably in their FIAX 
titers (Oto 240), all undiluted sera were capable of neutralizing 
cytotoxin-S as evidenced by PI's of at least 0.85. There was essentially 
no correlation between the PI's of undiluted sera and FIAX titers or 
LS's (Figures 6.4 and 6.5). Adsorption of sera with formalized.!:.:_ 
haemolytica had essentially no effect on their calculated PI's (Table 
6.3). In addition, crude IgG fractions of four sera were as capable 
of neutralization as were the whole sera from which each was derived 
(Table 6.3). 
_TABLE 6.3 
COMPARISON OF PROTECTION INDICES CALCULATED FOR CRUDE IgG FRACTIONS 
AND PREADSORBED BOVINE SERA VERSUS THEIR NATIVE SERA 
Pia of PI of IgG PI of 
Undiluted Serum Fractionb Adsorbed 
Serum A 0.85 ± 0.04 1.0 0.84 ± 
Serum B 0.92 ± 0.05 0.94 ± 0.07 0.86 ± 
Serum c 0.88 ± 0.13 0.92 ± 0.12 
Serum D 0.80 ± 0.23 0.91 ± 0.13 
~I= Protection Index. Values represent the mean± standard 
deviation. 





cSera were pre-adsorbed for 30 min with formalized decapsulated 
organisms. 
c 
Figure 6.4. FIAX Titer vs. Protection Index of Undiluted Serum. 
Regression curve for protection index of undiluted 
bovine sera vs. FIAX titers. 
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Figure 6.5. Lesion Score vs. Protection. Index of Undiluted Serum. 
Regression curve for protection index of undiluted 
bovine sera vs. lesion scores. 
152 
LESION SCORE VS PROTECTION INDEX OF UNDILUTED SERUM 
1. 
•A D 0 D D 







z O UNEXPOSED 
Q 0.6 c NATURAL EXPOSURE 
I- A LIVE VACCINE SUBCUTANEOUS 
0 • LIVE VACCINE INTRADERMAL w 
I- O KILLED VACCINE SUBCUTANEOUS 




2 4 6 8 10 12 
__, 
14 16 18 20 
LESION SCORE 
153 
In Situ Neutralization of Cytotoxin-S 
As with pre-formed cytotoxin, so chicken anti cytotoxin-B 
neutralized or prevented in situ cytotoxin formation but chicken 
anti CE serum did not (Table 6.4). All six bovine sera neutralized 
or prevented cytotoxin formation in situ to a degree comparable to that 
found in the standard neutralization assay (Table 6.4). The culture 
supernatants were not toxic regardless of whether the antiserum 
increased or reduced the viable count of the bacteria during incubation 
(data not shown). 
TABLE 6.4 
COMPARISON OF PROTECTION INDICES CALCULATED IN IN SITU 
NEUTRALIZATION ASSAY AND STANDARD 
NEUTRALIZATION ASSAYS 
Pia in Pia in 
"in situ" Standard 
Serum Tested Assayb Assayc 
Chicken anti Cytotoxin-B 0.90 0.96 ± 0.05 
Chicken anti capsular extract 0 .15 0.03 ± 0.03 
Bovine Serum A 0.91 0.85 ± 0.04 
Bovine Serum B 0.99 0.92 ± 0.05 
Bovine Serum C 0.88 0.88 ± 0.13 
Bovine Serum D 0.71 0.80 ± 0.23 
Bovine Serum E 0.76 0.81 ± 0.04 
Bovine Serum F 0.92 0.80 ± 0 .11 
aPI = Protection Index. 
b Represents result from a single trial. 
~ean ± standard deviation in 3-5 trials. 
Titration of Cytotoxin Neutralizing 
Capacity for Bovine Sera 
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Because all of the bovine sera tested were capable of neutralizing 
cytotoxin, titration curves were performed on two sera to determine if 
the neutralizing capacities of the sera were comparable. Sera were 
from an unvaccinated control calf and an animal immunized repeatedly 
with live~ haemolytica type 1 organisms. At the lowest serum dilu-
tions, both sera were equally capable of neutralizing cytotoxin-S 
(Figure 6.6). However, serum from the vaccinated animal was capable 
of neutralization at an 8-fold higher dilution than was serum from the 
unvaccinated animal. Serum titration curves were then performed for 
all of the 22 bovine sera included in the original study. The highest 
dilution of a serum still affording a PI of at least 0.80 was designated 
as the CN titer for that particular serum. Regression analyses of the 
CN titers versus FIAX titers and LS's indicated correlation coefficients 
of 0.54 (p < 0.01) and -0.76 (p < 0.001), respectively (Figures 6.7 and 
6.8). 
Comparison of Bovine Treatment Groups 
The mean PI for all bovine treatment groups using undiluted serum 
ranged from 0.91 to 0.98. There were no significant differences in 
mean PI's among groups (p > 0.05). The unexposed group of animals had 
the highest mean lesion score, the lowest mean FIAX titer, and the 
lowest mean CN titer. The group of animals considered to have been 
naturally exposed to the organism had a lower mean lesion score than 
the unexposed group, and the highest mean FIAX titer and the second 
highest mean CN titer of all groups (Table 6.5). 
Figure 6.6. Effect of Serum Dilution on Cytotoxin Neutralizing 
Capacity of Bovine Serum. Diluted sera were 
preincubated for_lO min at 37° C with cytotoxin-S 
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Figure 6.7. Cytotoxin Neutralization Titer vs. FIAX Titer. 
Regression curve for cytotoxin neutralization titer 
of bovine sera vs. FIAX titers. 
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CYTOTOXIN NEUTRALIZATION TITER VS FIAX TITER 
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Figure 6.8. Cytotoxin Neutralization Titer vs. Lesion Score. 
Regression curve for cytotoxin neutralization titer 
of bovine sera vs. lesion scores. 
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PARAMETER MEANS FOR BOVINE TREATMENT GROUPS 
Number of Lesion FIAX CN 
Treatment Group Animals Score Titer Titer 
Unexposed 5 16.8 2.5 5.2 
Natural Exposure 5 4.2 148.6 32.2 
Live Vaccine 6 1.8 131.8 45.4 
Subcutaneous 3 1.3 157.3 25.5 
Intradermal 3 2.2 110.5 80.7 
Killed Vaccine 6 11.3 105.9 7.9 
Subcutaneous 3 8.8 166.0 10.0 
Intradermal 3 13.8 67.6 6.3 
Comparison of the live vaccine and killed vaccine groups revealed 
that the live vaccine group had significantly lower LS's (p < 0.001) 
and higher CN titers (p < 0.02), while the FIAX titers for the two 
groups did not differ significantly (p > 0.10) (Table 6.5). The mean 
parameters for the live vaccine group closely paralleled those 
calculated for the group of naturally exposed animals; only their LS's 
were significantly lower (p < 0.05). At the same level of significance, 
the killed vaccine group had higher LS's and lower CN titers than the 
natural exposure group but their FIAX titers were not different. The 
killed vaccine group's parameter means for lesion score and CN titer 
did not differ significantly (p > 0.05) from those found for the group 
of unexposed animals. The only parameter significantly different 
(p < 0.05) for these two groups was their FIAX titers. 
162 
Comparison of the FIAX titers for the two vaccination routes 
utilized with killed vaccine revealed that the titers induced by the 
subcutaneous route were significantly higher (p < 0.05) than those 
induced by the intradermal route (Table 6.5). In contrast, when live 
vaccine was used, the FIAX titers induced by the two vaccination routes 
did not differ significantly (p > 0.05). However, injection of live 
organisms by the intradermal route stimulated higher CN titers and 
higher lesion scores than did injection by the subcutaneous route. 
Discussion 
The concurrent production of cytotoxin and capsular material by 
K.!_ haemolytica might suggest that the two products are related. 
However, in the present studies, we were unable to demonstrate that 
the extracted capsular material was cytotoxic. This lack of toxicity 
apparently was not due to a simple dilution effect, because even a 10-
fold concentrate of CE was not appreciably toxic. A second possibility, 
that the 41° Cheat treatment used in capsular extraction may have 
inactivated any cytotoxin present in the CE, does not appear valid 
either because cytotoxin-S remained toxic after simulated capsular 
extraction. Finally, efforts to neutralize cytotoxin with antisera 
from chickens immunized with CE were also unsuccessful, leading to the 
conclusion that there is not a significant amount of recognizable 
cytotoxin in CE as prepared in these studies. 
Sera from chickens immunized with cytotoxin-S were toxic to 
bovine PMN's and could not be used in the cytotoxin neutralization 
assay. Assuming the problem to be due to antibodies formed to the 
FBS included in cytotoxin-S, we attempted to circumvent the problem 
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by replacing the FBS with chicken ovalbumin (cytotoxin-S-OA). 
Apparently little toxin was produced in this medium because the 
product was only slightly toxic for bovine PMN's and did not stimulate 
formation of antiserum in chickens which would neutralize cytotoxin-S. 
Cytotoxin-B, which was prepared by a longer incubation in an unsupple-
mented medium, was also less toxic for bovine cells than was cytotoxin-S. 
However, in contrast to cytotoxin-S-OA, it stimulated the formation 
of antiserum in chickens that was capable of complete neutralization 
of cytotoxin-S. Perhaps tne prolonged incubation used in preparation 
of cytotoxin-B allowed for production and subsequent inactivation of 
cytotoxin, leading to a decrease in toxicity without loss of anti-
genicity. From these data it appears, then, that FBS is a necessary 
component of the incubation medium for formation of a maximally toxic 
product. 
Serum from chickens injected with live~ haemolytica organisms 
did not neutralize cytotoxin-S. This would imply that this organism, 
which is not a pathogen for chickens, does not multiply to any great 
extent in this species, or at least that it cannot produce cytotoxin 
in this unusual environment. 
The reason that all bovine sera other than FBS were capable of 
neutralizing cytotoxin-S in the undiluted state is unclear. Even 
animals whose FIAX titers indicated that they had not previously been 
exposed to the organism had PI's of at least 0.80. These data were 
substantiated by similar results from the in situ neutralization 
experiment. It may be that the FIAX test, which measures the response 
to cell surface antigens, was not sensitive enough to detect a minimal 
immune response. It is also possible for the organism to colonize an 
animal's nasal mucosa without invading the submucosa or the remainder 
of the respiratory tract (Pass and Thomson, 1971). In such a circum-
stance it is conceivable for the animal's immune system to be 
stimulated by absorbed soluble toxin that may be produced on the nasal 
mucosa without making contact with cell surface antigens. 
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Preadsorption of sera with formalin-killed bacteria did not reduce 
the PI of the sera. This is further evidence that neutralization of 
cytotoxin is not mediated by antibodies directed against killed 
organisms. The lack of correlation between the PI calculated for 
undiluted sera and the LS's also indicates that the PI of undiluted 
serum is not a good measure of an animal's resistance to an experimental 
challenge with the organism. 
The (NH4) 2so4 precipitation of several antisera and the initial 
serum titration curves were performed to determine if the serum 
neutralizing capacity was due to an immunoglobulin or perhaps to 
another serum factor. The crude IgG fraction of four sera were found 
to neutralize as well as their native Sera. In addition, there was an 
8-fold increase in the dilution at which serum from an immunized calf 
was still capable of neutralizing cytotoxin compared to serum from an 
unexposed calf, leading to the conclusion that increased neutralizing 
capacity was due to an immune response. 
Prior exposure to live organisms, either naturally or by immuni-
zation, as measured by the FIAX titer and CN titer was an important 
determinant of the animals' ability to resist experimental challenge. 
Both such exposed groups had significantly higher FIAX and CN titers 
and lower LS's than the unexposed animals. Vaccination with killed 
organisms, however, only stimulated an increase in the animals' FIAX 
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titers. Neither the CN titers nor the LS's of the killed vaccine group 
were significantly different from those foun~ in the unexposed controls. 
Therefore, exposure to cell surface proteins on killed organisms did 
not result in a significant increase in production of cytotoxin 
neutralizing antibodies and also failed to adequately protect the 
animals from challenge with live K..:_ haemolytica. These data help to 
explain the consistent failure of K..:_ haemolytica bacterins to protect 
cattle adequately from pneumonic pasteurellosis (Carter, 1957; Friend 
et al., 1977; Wilkie, 1982). 
In this study, the sera from calves vaccinated by intradermal 
injection of live organisms had a greater capacity to neutralize cyto-
toxin than did sera from calves vaccinated by subcutaneous injection. 
The lesion scores, however, were somewhat lower for the animals 
vaccinated subcutaneously. The use of such small treatment groups 
makes it difficult to compare the two injection routes adequately. 
However, the differences shown bear further examination. 
In conclusion, although the capsular material and cytotoxin of 
P. haemolytica are both produced most abundantly during the early 
logarithmic growth phase of the organism, these studies failed to 
show any toxicological or immunological relationship between the two 
products. All undiluted bovine sera tested, . other than FBS, were 
capable of neutralizing cytotoxin. Sera varied, however, in their 
CN titers, and the animals' capability to resist an experimental 
P. haemolytica challenge closely correlated with these titers. 
Statistical evaluation of the animals' serum antibody levels to cell 
surface antigens as reflected in their FIAX titers did not predict 
this difference. These results thus lend support to the hypothesis 
that protection against experimental challenge with R..!_ haemolytica, 
type 1 may require an immune response to cytotoxin (Wilkie, 1982). 
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CHAPTER VII 
SUMMARY AND CONCLUSIONS 
The studies described herein were undertaken to examine the 
relationship of capsular material on Pasteurella haemolytica to the 
organism itself and to the organism's involvement in the bovine disease 
known as shipping fever or pneumonic pasteurellosis. 
Chapter II was concerned with microscopic demonstration of the 
capsular material by a fluorescent antibody and several capsular staining 
techniques. Wide capsules were demonstrated on organisms from 2- to 
6-hr cultures. The amount of capsular material diminished gradually 
as the culture aged, until little capsular material remained on 
organisms from cultures over 16 hr old. For capsule demonstration, 
Maneval's stain was determined to be superior to the other staining 
techniques. 
In Chapter III, it was determined that capsular material could be 
removed from the organisms by incubating them at several different 
temperatures in either distilled water or phosphate buffered saline 
(PBS). Criteria used to determine capsular removal included change in 
antibody-mediated agglutinability of the organisms and disappearance 
of an antigenic component by the fluorescent-antibody test and the 
agar-gel diffusion technique. Incubation of a PBS-suspension at 
41° C for 1 hr was determined to be the method of choice for removing 
capsules with a minimum decrease in culture viability. That method 
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was then used in subsequent experiments to provide comparable popula-
tions of encapsulated and decapsulated organisms, as well as capsular 
extracts. Extracts consisted of the PBS supernatants from centrifuged 
and filter-sterilized decapsulated bacterial suspensions. 
Chapter IV dealt with the .interactions of encapsulated organisms 
(EO) and decapsulated organisms (DO) with bovine sera. DO were more 
easily agglutinated than EO by antiserum prepared against intact 
organisms, whereas EO were more easily agglutinated than DO by anti-
serum prepared against a capsular extract from the bacterium. DO were 
found to be more sensitive than EO to the bactericidal action of bovine 
sera. High antibody titers, particularly to capsular material, were 
apparently needed for serum killing of EO, whereas DO were readily 
killed by sera even from animals with low antibody titers. Heat-
inactivation of the sera reduced the rate and the percentage of killing 
of both EO and DO. Addition of a fresh complement source partially 
restored the bactericidal activity of heat-inactivated sera. 
In Chapter V, EO and DO were also compared as to their interactions 
with bovine phagocytes. A viable counting technique was used to 
determine the% phagocytosis of the two types of organisms after 
opsonization with various heat-inactivated bovine sera. Neither EO 
nor DO were effectively phagocytized after opsonization by fetal bovine 
serum. After opsonization with either anti-live (AL) or anti-capsular 
(AC) serum, however, both types of organisms were phagocytized by 
bovine polymorphonuclear leukocytes (PMN) or pulmonary alveolar 
macrophages (PAM). The calculated% phagocytosis for EO was 2 and 10 
times higher than that calculated for DO after opsonization with AL 
or AC serum, respectively. Opsonizing capacity was shown to reside in 
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the IgG fractions of the sera. Intracellular killing of the organisms 
was shown to occur by transmission electron microscopy, and by a reduc-
tion in the calculated number of intracellular organisms during the 
assay. However, intracellular killing could not be demonstrated for 
either type .of organism by incubation of phagocytes after separation 
from unphagocytized bacteria by a differential centrifugation technique. 
Exposure of bovine PMN or PAM to either EO or DO resulted in death of 
the phagocytes, with PMN being somewhat more susceptible than PAM to 
the organisms' toxic effects. EO were more toxic than DO for PAM. 
In Chapter VI,.!'..:._ haemolytica capsular extract was compared to 
several preparations of cytotoxin from the organism. These experiments 
failed to show any immunological or toxicological relationships between 
the two products. In addition, a study was performed of the neutrali-
zation of.!'..:._ haemolytica cytotoxin by bovine sera from a number of 
animals with varying degrees and types of immune responses to.!'..:._ 
haemolytica. All undiluted sera tested, other than fetal bovine serum, 
were capable of neutralizing cytotoxin, regardless of their antibody 
titer against.!'..:._ haemolytica. However, the cytotoxin neutralizing 
capacities of the sera, as determined by titration curves, differed 
according to the type of prior exposure of the animals to the organism. 
Animals exposed to live organisms, either naturally or by immunization, 
had significantly higher cytotoxin neutralizing titers and significantly 
greater resistance to experimental disease than animals which were 
unexposed or vaccinated with bacterins. 
From the results determined in these studies, the following 
conclusions were drawn: 
1. Studies of capsular material on!:.!_ haemolytica should be 
carried out with early log-phase cultures in order t"o obtain maximally 
encapsulated organisms. 
2. Maneval's capsular staining method is a rapid and reliable 
technique for demonstration of!:.!_ haemolytica capsular material. 
3. Viable decapsulated !:.!_ haemolytica may be prepared by incuba-
tion of PBS suspensions of the organisms at 41° C for 1 hr. 
4. Capsular extracts of!:.!_ haemolytica prepared by the method 
above contain both protein and carbohydrate. They are innnunogenic for 
chickens and ~attle, but are not toxic to bovine phagocytes. 
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5. Encapsulated!:.!_ haemolytica are generally more resistant to 
serum agglutination than are nonencapsulated or decapsulated organisms. 
6. Capsular material on!:.!_ haemolytica from logarithmic-phase 
cultures appears to enhance resistance of the organisms to the 
bactericidal action of bovine serum. Complement is necessary for 
maximum bactericidal activity against either encapsulated or 
decapsulated organisms. 
7. Neither encapsulated nor decapsulated !:.!_ haemolytica are 
phagocytized by bovine PMN or PAM in the absence of specific antibody. 
8. Encapsulated!:.!_ haemolytica are phagocytized effectively by 
bovine phagocytes after opsonization with heat-inactivated antisera 
containing anti-capsular antibodies. Encapsulation does not appear 
to enhance resistance of the organisms to phagocytosis, at least in 
the presence of anti-capsular antibodies. 
9. Intracellular killing of!:.!_ haemolytica occurs after phago-
cytosis by bovine PAM. 
10. Both encapsulated and decapsulated K..=._ haemolytica are toxic 
to bovine phagocytes. 
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11. The capacity of an animal's serum to neutralize K..=._ haemolytica 
cytotoxin may be one important determinant of the animal's ability to 
resist experimental challenge with the organism. 
12. Induction of significant serum cytotoxin neutralization titers 
in cattle depends on exposure of the animals to live, metabolically 
active organisms. 
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